To return to CFDP home page: http://fox.nstn.ca/~eoscapel/cfdp/cfdp.html Debates of the House of Commons of Canada (Hansard) [NOTE: THIS EXCERPT DEALS ONLY WITH BILL C-7, THE CONTROLLED DRUGS AND SUBSTANCES ACT. OTHER PORTIONS OF HANSARD HAVE BEEN DELETED] (Bill C-7 died on February 2, 1996, with the ending of the 1st session of the 35th Parliament. However, on March 6, 1996, the House of Commons revived the former Bill C-7 as Bill C-8. Bill C-8 is identical to the Bill C-7 originally passed by the House on October 30, 1995, except that its number has changed to C-8. Accordingly, any statements made in the House about Bill C- 7 would apply equally to Bill C-8.) -- Eugene Oscapella, Canadian Foundation for Drug Policy ***************************************** Debates of the House of Commons of Canada (Hansard) Monday, October 30, 1995 GOVERNMENT ORDERS CONTROLLED DRUGS AND SUBSTANCES ACT Bill C-7. Report stage (with amendment) 15947 Motion 15947 Mr. Hill (Macleod) 15947 Ms. Fry 15947 Mr. Benoit 15948 (Motion negatived.) 15950 Motion for concurrence 15950 Mr. Dingwall 15950 (Motion agreed to.) 15950 Motion for third reading 15950 Mr. Dingwall 15950 Ms. Fry 15950 Mr. Hill (Macleod) 15953 Mr. Szabo 15954 Mr. Simmons 15960 Mrs. Ur 15962 CONTROLLED DRUGS AND SUBSTANCES ACT Bill C-7. Consideration resumed of motion forthird reading 15976 Mrs. Ur 15977 Mr. Maloney 15978 Ms. Brown (Oakville-Milton) 15979 Ms. Augustine 15981 Mr. Riis 15982 Ms. Fry 15983 Mr. Szabo 15984 Ms. Fry 15984 Mrs. Barnes 15984 Mr. Alcock 15988 (Motion agreed to, read the third time and passed.) 15988 Mr. Boudria 15988 Motion 15988 (Motion agreed to.) 15988 _________________________________________________ ______________________________________ 15947 GOVERNMENT ORDERS [English] CONTROLLED DRUGS AND SUBSTANCES ACT The House proceeded to the consideration of Bill C-7, an act respecting the control of certain drugs, their precursors and other substances and to amend certain other acts and repeal the Narcotic Control Act in consequence thereof, as reported (with amendments) from the committee. Mr. Grant Hill (Macleod, Ref.) moved: That Bill C-7, in clause 60, be amended by replacing lines 13 to 15, on page 44, with the following: ``portion of an item, after the governor in council has consulted with those persons who will be directly affected by the amendment''. Mr. Boudria: Mr. Speaker, I rise on a point of order. I understand unanimous consent is being sought to debate the amendment, even though it was not moved previously. I indicate to the Chair that we do not have any objection to it. We concur, with the understanding that we will immediately go to third reading after the amendment is disposed of. Mr. Hill (Macleod): Mr. Speaker, we are seeking unanimous support and agree to third reading going ahead with the same support. The Acting Speaker (Mr. Kilger): Is there unanimous consent? Some hon. members: Agreed. Mr. Hill (Macleod): Mr. Speaker, Bill C-7 has been a complex bill that has taken some time going through the House. There is some vast improvement in the bill by opening up choice in the health food industry. However the power to make regulation is still flawed in relation to the bill. The particular clause we have zeroed in on is clause 60: The governor in council may, by order, amend any of schedules I to VI by adding to them or deleting from them any item or portion of an item, where the governor in council deems the amendment to be necessary in the public interest. I have a few words to say about that clause. I believe it is dictatorial, arbitrary and opaque. Other words that come to mind are words like behind closed doors. This ability should not rest in the hands of a few. The particular amendment suggested will address a significant flaw. One of my colleagues will speak at length on the issue a little later. Ms. Hedy Fry (Parliamentary Secretary to Minister of Health, Lib.): Mr. Speaker, I rise to speak to the third party amendment to clause 60 of Bill C-7. I agree with the hon. member the bill is a complex and at times controversial bill. All parties were eventually unanimous in the substantive changes and amendments to the bill that improve the bill a great deal. However I speak to the specific amendment of the hon. member to clause 60 that would read: ``portion of an item, after the governor in council has consulted with those persons who will be directly affected by the amendment''. The purpose of the amendment is to get the governor in council to consult with those who would be directly affected by a change in schedule made by the governor in council. There is already in place a democratic process within the machinery of government that answers the particular concern the hon. member for Macleod brought forward. Government is required to consult with those who will be affected by the proposal and the public at large before making any changes. (1205 ) The only exception to this requirement is where public safety is concerned and where on an urgent and emergency basis one needs to make a change to the schedule within 24 hours. Even then there 15948 is a process wherein an emergency scheduling provision in the interests of safety of the public would allow it to happen. Turning to the broader process the member is speaking about, the process provides for the machinery of government. Government is required to prepublish for a minimum period of 30 days in The Canada Gazette, part I, any proposal to change scheduling. The prepublication period may vary, depending on the nature of the proposal. For example, if the proposal was to have international implications and would therefore have impact on GATT, there is an agreement in GATT that there would be a minimum of 75 days of prepublication to allow other countries to respond. Not only would interested parties respond if this were done a national level. Any citizen at all could provide comments or suggestions about the content of the proposal and about their concerns on the proposal. Then the government is obliged to report to the governor in council on those consultations, the feedback or input from parties directly affected, from concerned citizens or from the public at large. Also it is to report on the proposed remedies to be brought forth to address concerns. If this amendment represents a major shift in the original proposal, and if the concerned parties that have had input want another shift, there is a requirement to prepublish once again to discuss the new shift. All the bells, whistles and hoops have been jumped through in the process already so I fail to see what the hon. member's amendment would do to improve the process in any way, shape or form. It is already public. It is already open to disclosure. If disclosure requires change there is a requirement for further disclosure and for a further period of 30 days to discuss it. As I said before, internationally there is a requirement to prepublish for 75 days. There is a fail safe mechanism already there to answer the hon. member's concerns about the issue. Mr. Leon E. Benoit (Vegreville, Ref.): Mr. Speaker, I am pleased to rise today to speak to the amendment to clause 60 of Bill C-7. It says that the clause should be amended by replacing lines 13 to 15 on page 44 with the following: ``portion of an item, after the governor in council has consulted with those persons who will be directly affected by the amendment''. The parliamentary secretary responded to the amendment by asking why we need it. We already have the proper bells and whistles in place to deal with the public consultation process. The parliamentary secretary to the health minister is correct. The amendment will put in place the requirement for public discussion and public consultation on changes to the bill. In many pieces of legislation the Liberals have succeeded in taking more and more power from the people by putting in place the ability to make changes to legislation through the governor in council. This is one such move on the part of the government. The most important example in Bill C-68, the gun control legislation, gives incredible power to the governor in council. Bill C-61 deals with several agricultural acts and gives the minister and the bureaucrats the power to impose fines of up to $15,000 with the onus on the people fined to prove their innocence. That is one negative point about the legislation. Another is the control given through the governor in council without debate happening in the House. That is not democratic. (1210) Unfortunately the anti-democratic move in the bill that gives more power and ability to make more decisions through governor in council is not unusual. The government has shown in many ways that it does not want to make things more democratic in the House. We have seen through what has happened to members who dared to vote against their party line or against the government on bills such as the gun control bill, Bill C-41. I could name others. These members have been punished harshly for voting differently than the party position. They have been thrown off committees and the Prime Minister publicly threatened to refuse to sign their nomination papers. What kind of a democracy is that? The amendment will at least ensure a small amount of consultation. Liberal consultation is different from the Reform's version of consultation. Reform believes that when we go to the people to ask for consultations we really want to hear what they have to say and to act on it. The Liberals have shown that is not what they see as consultation. For example, in the gun control bill the justice minister's idea of consultation was to have meetings to which people went by invitation only. Other interested people were not welcome. That was complete and utter nonsense. The amendment will in a small way give a bit of the power back to the people by requiring consultation. I will refer to a couple of other amendments but first I will show that this amendment has in a small way dealt with the concerns of some of my constituents. I have found that Bill C-7 and the changes to the legislation are very important to people in my constituency. Many people have come to me in public meetings asking questions about specific clauses of the legislation, and this is one of them. People have written letters to me that refer to specific clauses of the legislation. I will read a letter from one of my constituents. It is a form letter but personal comments are included with it. It represents the concerns of a wide number of people, often people who want access to herbs, spices or other traditional medicines. They do not want the pharmaceutical companies or the government to be able 15949 to limit access to these products in some way. It is very important to them. The letter states: I'm writing to request that Bill C-7 be withdrawn. That is what should have happened with the legislation. It should have been withdrawn, or at least large parts of it should have been withdrawn. It is an omnibus bill that deals with many parts of the act. It is so broad or wide ranging that I wonder how the House of Commons can be asked to vote on the bill. It would be far more useful to have more specific legislation dealing with similar concerns. Not all parts of the legislation should be thrown out. There are many good parts. However, because it is an omnibus bill and deals with a wide range of issues, parts of it should certainly be thrown out. The letter refers to the parts this constituent feels should be thrown out. A good summary of the legislation is given: Bill C-7, the Controlled Substances Act, combines the Narcotic Control Act with the portions of the Food and Drugs Act. Combining criminal law with regulatory health is inappropriate and puts my right to buy natural health products in serious jeopardy. Bill C-7 is a Criminal Code framework which would implicate many common herbal remedies and natural supplements because of their ``stimulant'' or ``relaxant'' properties. I believe that public safety can be ensured without Criminal Code restrictions on food supplements- (1215) Mr. Szabo: On a point of order, Mr. Speaker, my understanding of the rules of this place is that a speaker must speak to the subject matter before the House. We are now dealing at report stage with a specific amendment. The member is speaking about the whole bill. The Acting Speaker (Mr. Kilger): With the greatest of respect, that is a matter of debate and not a point of order. Mr. Benoit: Mr. Speaker, I am surprised by the continual interruptions on the part of members opposite when we try to make a point on behalf of our constituents. It is was important enough to my constituents to write this letter to me. That member does not want to let me rise in the House and read this letter and show how this amendment has at least in some small way dealt with this concern. That is anti-democratic. It is just one more thing. It is the Liberal way. It is not democratic and it is not what we expect in the House. I become upset when I have this type of an interruption. The letter goes on to say: Further, I object that the control of any bioactive components or synthetic analogues of natural herbs by Bill C-7 it will replace criminal sanctions to the herbs themselves. Health Canada should not be allowed to seize, remove or illegalize safe products from the shelves of distributors or hold them at the border without clear and convincing evidence of a lack of safety or misbranding. Health Canada should bear the burden of proof. I believe that natural herbs and health supplements do not belong in the Criminal Code. These products should be considered as dietary supplements and regulated as such. Natural substances should not be considered as drugs. I expect that you will represent my interests and oppose Bill C-7. We will of course oppose Bill C-7. If this amendment does pass, and I would be surprised if it did not, all it does is put in place a consultation process. There is nothing guaranteeing it will be a valid consultation process but it is certainly a move forward. The onus will be on the government to show that it has consulted. If we as an opposition party ask the government to show us it has consulted, it will be forced to at least demonstrate that it has had some consultation with all interested parties. Other things have happened with this bill; other amendments and really the deletion of one clause I think has been extremely important. I credit my colleague, the member for Macleod, for successfully having clause 3(1) removed. It is certainly an important change to this legislation. (1220) Clause 3(1): For purposes of this act a substance included in Schedules I, II or III shall be deemed to include any substance; (a) that is produced, processed or provided by a person who intends that it be introduced into the body of another person for the purpose of producing a stimulant, depressant or hallucinogenic effect substantially similar to or greater than that of a substance included in Schedule I, II or III, and that, if so introduced, would produce such a substantially similar or greater effect; or (b) that is represented or held out to produce, if introduced into a human body, a stimulant, depressant or hallucinogenic effect substantially similar to or greater than that of a substance included in Schedule I, II or III. Again I congratulate my colleague for successfully having that clause thrown out. That is a substantial change to this bill and it will help. Unfortunately there are still so many concerns- The Acting Speaker (Mr. Kilger): I regret the member's time has elapsed at report stage. Is the House ready for the question? Some hon. members: Question. The Acting Speaker (Mr. Kilger): Is it the pleasure of the House to adopt the motion? Some hon. members: No. Some hon. members: On division. 15950 (Motion negatived.) Hon. David Dingwall (for the Minister of Health, Lib.) moved that the bill be concurred in. The Acting Speaker (Mr. Kilger): Is it the pleasure of the House to adopt the motion? Some hon. members: Agreed. Some hon. members: On division. (Motion agreed to.) The Acting Speaker (Mr. Kilger): When shall the bill be read the third time? By unanimous consent now? Some hon. members: Agreed. Hon. David Dingwall (for the Minister of Health, Lib.) moved that the bill be read the third time and passed. Ms. Hedy Fry (Parliamentary Secretary to Minister of Health, Lib.): Mr. Speaker, I rise to speak in support of Bill C-7. The revisions to the bill, the changes made since it passed second reading in the House, combine two quite different approaches to the control of drugs. The approaches are different but they are actually complementary. The first enshrines an attitude of tolerance, compassion and concern for the drug addicted person. The government believes that someone convicted of a drug offence, a user who shows genuine desire to recover from his or her addiction deserves the chance and opportunity to rebuild and renew their lives on a healthy, law-abiding basis. This component speaks therefore of rehabilitation and speaks to the health aspect of drug use. (1225 ) The second approach is to reinforce our longstanding condemnation of violent behaviour or any drug dealing that harms our youth and other vulnerable citizens. The government believes drug offences and the negative social impact of drug offences escalate directly in proportion to the age of the person, which means the younger the person, the greater the social and physical harm that occurs as a result of the use of drugs. These approaches to the control of drugs reflect the spirit of the red book ``Creating Opportunity''. A principal objective of this book is to strengthen Canadian society by protecting individuals from crime and violence on the streets and in the playgrounds. Bill C-7 works to achieve this end. It clearly identifies a need for extra protection against crimes around schools where young people are involved. However, it goes further in creating opportunity. It creates opportunity for offenders to get treatment. It creates opportunity for enforcement to be more effective. It creates opportunity for the justice system to deal more even handedly with the various substances and offences that are the subject of the bill. Bill C-7 is more than a housekeeping bill. It achieves a balance between the need for compassionate health and social components of drug use and the need to punish and deal with the criminal and violent aspects of drug use. True to this purpose, we have brought the Narcotic Control Act and parts of the Food and Drugs Act together to deal with controlled substances and narcotic preparations. It modernizes procedure to a certain extent. It expands control over a wider range of substances, but it is more comprehensive than that. In the case of one substance that has caused major concern for policy makers and the public over many years, it incorporates a revised and more current understanding of how Canadians want to deal with marijuana. Cannabis and its derivatives from now on will have a distinct schedule in the bill, schedule I(i). Cannabis has been set apart from other hard drugs. It is being treated separately. As we will see from this amended bill, government has taken very seriously the concerns expressed by witnesses of committee hearings and also by members of the House who have come together to tell us what they think of the bill. I am therefore pleased to say changes and measures have been instituted in order to reflect a more Liberal policy with regard to harm reduction, rehabilitation and the societal aspects of drug use. Hon. members know the consultative process is inherent and very important in the parliamentary committee system. Committees collect the views of people on the street. One of the strengths of the process is that it brings forward a range of opinions and perspectives not necessarily obvious to those who prepare the original drafts of legislation. On this note I congratulate all members of the subcommittee from all parties and thank all witnesses who provided testimony on this legislation. When we start talking about illicit substances such as marijuana and cocaine people want to broaden the horizons. Many of the witnesses who came to the subcommittee on health were not really addressing Bill C-7 specifically. They wanted to put broader issues on the agenda such as a more socially responsible approach to dealing with cannabis. It is argued there may be times when people are guilty of simple possession by aberration. They have been to a party, accepted a gift and have been caught. In such a circumstance the criminal mark should not be on record for the rest of their lives. It cannot be denied that a large number of Canadians are at least tolerant of soft drug use. They have heard a former Prime Minister and the President of the United States admit to experimenting with 15951 marijuana. They see courts routinely granting absolute or conditional discharges for simple possession charges while imposing fines for simple traffic violations. Some people in subcommittee were even saying we should decriminalize marijuana. However, by international law we cannot decriminalize it. We have to consider it a criminal offence but we can deal with the consequences associated with marijuana. That is one of the changes that has come through in this newly amended bill. Specifically for possession of marijuana, 30 grams or less, we have reduced the seriousness of the offence. The negative impact on someone charged with this offence will be changed. No fingerprints or photographs will be taken by police officers. No traceable record will appear in national criminal databases. The law has been modified. (1230) This does not mean that the penalties have been reduced. They have not. The penalty for possession of 30 grams or less of cannabis continues to be a $1,000 fine or six months or both. It is the ancillary impacts that will change. A conviction on this charge will not curb one's ability to travel internationally, for instance. It will not interfere with getting a job. Another concern raised in subcommittee was to put something in the bill to ask the courts to move toward rehabilitation and treatment instead of automatically treating all users as hardened criminals. Therefore, the introduction of section 11, which deals with sentencing, addresses this concern. Judges are encouraged to order rehabilitation and treatment in appropriate circumstances. This said, it was not the government's intention that the bill would alter or review existing drug policy. It was meant to bring aspects of administration up to date from existing legislation that dates back to the 1960s, and it gives effect to Canada's commitments on the various international agreements dealing with narcotics and psychotropic substances. There is a change in penalties for trafficking in three kilograms of cannabis or less. Here the maximum penalty is lowered from 14 years down to five years less a day. The reason for this is not because the gravity of the offence has been diminished. In fact, the subcommittee wanted to deal with trafficking as harshly. However, the lesser sentence achieves another goal: it leads to a streamlining of the judicial process. It hastens cases through the courts by eliminating requirements for preliminary hearings and trials by jury. It is not expected to change actual sentencing patterns. Even though the courts have been able to go to 14 years, they have not really been giving sentences anywhere near that length. From now on drug charges will represent the true offences. Until now, when trafficking has been the issue prosecutors would often reduce it to a possession charge, rather than proceed through a full pre-trial and trial by jury. Now prosecutors will be more likely to lay the charges they should have been laying. In fact there is no intention to give any signal that the penalties that are currently being given for the offence are not appropriate. This is not getting soft on traffickers. Streamlining the prosecution of these offences would be a net gain for the criminal justice process but would not mean an actual reduction in sentences, given current practice. I alluded to the approach this bill takes to discouraging violence and any drug dealings involving youth. The approach is simply the following. Offences under Bill C-7 have penalties attached to them, including imprisonment. Judges have discretion in sentencing and may choose not to impose a prison sentence in any particular case. However, if an offence is accompanied by violence or the threat of violence, or if it takes place in or near the grounds of a school, or if it involves dealing with someone under the age of 18, the court is to consider any of these circumstances an aggravating factor. If it decides in such a case not to impose a prison sentence, then the bill requires that the court give reasons for such a decision. There are very substantive changes between the current Bill C-7 we are discussing and its original version. I have mentioned the instructions to the court to consider rehabilitation and treatment at sentencing and the reduction in the impact of a conviction for simple possession of cannabis. The following is a representative sample of a dozen or more other changes to the bill. The previous subsection 3(1), which dealt with controlling unlisted substances that have an effect similar to scheduled drugs, has been completely removed. It has been deleted. It had been objected that the conduct subject to criminal sanction in this subsection had not been specified enough and that herbs or natural extracts might be captured. Removing this subsection should remove all doubts on that score to those who sell herbs and have been concerned about this. It is no longer going to affect an individual even if they thought it might have. Now they need not worry on that count. Subsection 30(1) has been amended to ensure that inspectors have reasonable grounds to believe that a place is used for an illicit purpose mentioned in the bill before entering the place. Paragraph 30(1)(c) is amended to exclude the possibility that inspectors can examine a person's medical record and therefore infringe on the confidentiality between physician and patient. (1235 ) Paragraph 54(1)(h) is amended to eliminate any risk that regulations made under the act could apply to medical practitioners or other professionals who are not targeted. That was a concern from those professionals who under the act were licensed to give prescription drugs. However, the definition of trafficking has been 15952 broadened to include the sale by a licensed practitioner of a prescription to obtain drugs. Every one of the concerns raised in subcommittee has been carefully examined in the reconstruction of this bill. This is not to say that every concern that was expressed has led to an amendment. Some were felt to be without foundation, such as the fear that the bill would threaten the viability of the existing needle exchange program. It was decided after examination that there was no such threat and there needed to be no amendment. Other observations or criticisms will be more properly addressed in a general drug policy review rather than in Bill C-7. In fact that was a recommendation from the committee. It has been suggested by some that this is not a health bill. Many of the issues that have come up deal with justice and enforcement. It should be made abundantly clear that controlled substances are not all bad substances. Many of them indeed are very good when used as prescribed. They are important to the health of the nation. They are major tools in the medical kit. Drugs and drug abuse are basically social and health problems. They find their way, however, into the criminal justice system not because they naturally and necessarily belong there, but because we have yet to devise a better method of control. Prohibition has had very limited success and very high cost. Many believe that programs to increase awareness, education, and treatment would be more successful for less money and less violence in drug enforcement. In fact the main thrust of Bill C-7 is that it allows for these controlled substances to be used for medical and scientific purposes. We need codeine and morphine and similar drugs to treat patients. Unfortunately, they are also subject to abuse. Therefore, we need to build into the law how we deal with their diversion to non-medical purposes and their abuse potential. That is where most of the justice issues come into play in this bill. The bill facilitates the placing of safeguards at all levels of production and distribution of high-risk drugs and allows them to be used as prescription drugs. This reduces the risk that drugs produced for legitimate purposes would be diverted into the illegal street market. Canadians will have access, as before, to physicians, dentists, pharmacists, and other licensed health care providers for whatever drug they need to treat their illnesses. They need not be concerned about that. Bill C-7 is not a catch-all for pharmaceutical preparations. It does not affect antibiotics, for example. It names clearly the drugs it would control, which are generally those used to treat pain and many psychotrophic or mood-modifying drugs. By including the concepts of treatment and rehabilitation, this bill also acknowledges the important health dimensions of drug abuse. It begins to rebalance that emphasis on substance over user and coercion over persuasion. It is not a new policy and it is not even a big change, but it is an important shift in perspective. It opens the way to alternate approaches and choices in addressing a disease that afflicts hundreds of thousands of Canadians and the social well-being of Canada. Bill C-7 is meant to control dangerous substances. We want to control these substances because in the wrong hands and used in the wrong way they can cause great harm to Canadians and to the social fabric of this country. I say this even though I recognize that drug use is not a major concern for Canadians in general. In fact an Environics poll that focused on justice and crime issues last year found that only two per cent of respondents said that illicit drug use personally troubled them far more than other crimes. This was far behind phenomena such as domestic violence, youth gangs, breaking and entering, and crimes against children. There is another reason to control these drugs, and I believe it is a far more important reason. Many substances we are dealing with here have strong medical components. This bill aims to make them available to health professionals and their patients for legitimate medical purposes. These substances, as I said before, are an essential part of our armaments against human suffering. We need painkillers, tranquillizers, and similar drugs to treat patients suffering from pain, anxiety, stress, depression, and other illnesses that in fact are born of our age of worry and anxiety. These are substances for medical use. (1240) Because Bill C-7 sharpens the tools we use to control the production and distribution of high-risk preparations that can be made available safely for prescription drugs does not mean that we are condemning those drugs. Patients will continue to have access to prescriptions through their doctors and pharmacists. Patients will always have what they need to treat illness and the medical records of patients will not be violated. Health Canada's goals and priorities have repeatedly found support from the Canadian public, who rate the performance of health care in the current system at the very top of government activities. This is from Ekos Research. Side by side with medicare on Health Canada's priority list is the protection against risks to Canadians' health. Therefore, illegally obtained and unsafe drugs are among those risks. Drug dependence is not only a criminal issue, it is very much a health and social issue. With some of these amendments we have tried to bring a positive approach to treatment programs for those who are afflicted by drug addictions. We support the help and appropriate treatment 15953 for those who want to get back their health and resume a normal life. We will continue to authorize methadone treatment for those who have a drug dependence. Methadone, as members will know, is a controlled substance that assists many opiate users to re-establish a constructive life. I want to assure the House that is not changing. The department is also responsible for the national program to reduce the spread of HIV and AIDS. We will not be affecting the needle exchange programs, which in many communities have had massive positive results and have been so successful in curbing the spread of HIV among intravenous drug users. Medical devices such as needles were deliberately excluded from criminal sanctions in Bill C-7. So this effective public health program in fact will continue its good work. The bill protects the rational use of some controlled substances as medicines while acting against the illicit distribution of these same substances. It recognizes that controlled drugs are indispensable and that their availability should not be restricted or compromised. It promotes the judicious use of medications by indicating ways in which controlled drugs can be handled, distributed, and used. These substances are included in the legislation, as I said, to protect the health and safety of the public. For example, Bill C-7 makes it possible for cancer patients and those who are terminally ill to obtain pain relief from prescribed medications such as morphine. In a hospital setting or for out-patients under strict medical supervision, even heroin is available for the treatment of pain and suffering. This legislation ensures that cocaine can be safely used in examination and in surgical procedures. Other medications aimed at treating less severe but still incapacitating conditions such as migraines are contained in the schedule of substances we are dealing with here. These will continue to be made accessible under this bill. Some of these drugs are also used on the street and therefore are subject to trafficking. While these substances all have the opportunity to create good and help patients who are ill, they have a strong potential for abuse. It is not surprising that the enforcement aspect of Bill C-7 has therefore attracted attention. But we must not forget that access to these substances must be preserved for the benefit of all those who are afflicted, which may include a majority of Canadians at some time in their lives. These substances are powerful. They have the power to do good, but also the power to do harm. If a drug is prescribed by a physician and if you use it more than is prescribed by a physician, the addictive properties of these drugs could be forgotten. We do not want that harm to occur to patients. As legislators, our task is to find a balance that will maximize good and minimize harm. I believe we have struck the appropriate balance in this legislation. I urge hon. members of the House to support it, as I will. Mr. Grant Hill (Macleod, Ref.): Mr. Speaker, good old Bill C-7 has been with us since my arrival in the House and I have followed it with fascination. It was of course a Tory bill introduced before this Parliament sat and was opposed then by my Liberal colleagues. I watched as it became a Liberal bill and was embraced with some degree of enthusiasm. (1245) I invite people listening today to reflect on the parliamentary secretary's words during her original speech on this bill. I am sure they will find that the parliamentary secretary wholeheartedly supported Bill C-7 in its unmodified form. To be kind, that wholehearted support was somewhat enthusiastic. This bill has gone through such a dramatic change in the committee process. That is what I am going to spend my time on today. Can the public influence a bill? The general perception in Canada is that the public cannot influence a bill. The fact is that the public can influence a bill, not only its tone but its actual final outcome. What actually happened during the process of modifying this bill? I found, as did many people in Canada, that clause 3(1) and (2) could have significant potential harm to the health food industry. This clause stated that substances could be deemed to have a stimulant, depressant or hallucinogenic effect. It was plunked into the bill. Individuals across the country said it was too broad, too vague and not specific enough. I received a host of requests for information. As an opposition health critic people said to me: ``This seems to us to be a point where an opposition critic should step up to the plate''. What did we do? We formed a very specific newsletter, which I have with me today. It states: ``C-7 threatens choice in health care''. It also mentioned areas of this bill that could have a profound effect on health care. The newsletters went out along with a request for petitions to health food stores and to individuals who wrote asking for more information. To me, the outpouring of support for this position of choice in health care was profound. I wish I could touch that nerve in other areas. I wish I could touch the nerve of the health food industry in other areas. People contacted the subcommittee on health. I am convinced the committee members could not believe the outpouring. People contacted the minister, their MPs and me. Did I have a big role in this? I was only able to provide a small vehicle for the outpouring of personal sentiment. I do not put myself as a great individual in this debate at all, but the focus of the input was fascinating to me. The whole issue was choice in health care. Those individuals said: ``Deny us that choice and you are treading on our toes''. The result and specific part of the bill I found so offensive was the ability for legislators to deem substances such as stimulants, 15954 depressants and hallucinogens to be stricken completely. There has not been a great deal of fanfare about that. I want to tell the Canadian public that this was a huge victory for those who wanted to choose what they take. There are those who say that people could make mistakes in their lives and I agree with that. However, when should regulators be involved in someone's personal decision making? When there is proven harm, when there are potential side effects, and when there is fraud in claims, doses, source or contents. Otherwise the public tells the legislators to step aside. No one knows better than the individual how they feel and what works for them when it comes to things they take into their body. (1250 ) There is a price for this freedom. The price for the freedom is to be informed. The public says: ``Government stand aside; we have spoken''. I finally say to those who would regulate and legislate in this area, no one can be better informed than the citizen who has a need which is not met by bureaucrats and legislators, driven by internal pain, anxiety or wants. They want to seek out time honoured remedies. They said loudly and clearly: ``You will never usurp this right''. People find that interesting coming from a physician and surgeon, someone who occasionally is criticized for being too narrow in focus. I have seen individuals not helped by my profession. I have seen individuals seek alternative therapies. I have seen individuals beg for the ability to do that. I believe they have and need the right to do exactly that. Why did we bring an amendment to this bill, a bill that frankly has dramatically improved over the way it first came to this House? We brought an amendment because there is still a regulatory mechanism, the power to make regulations which still gives the government the power it had in clause 3, to deem something to be included in the bill without broad public debate. Is the mechanism of public consultation sufficient? In my view it is not. When something is put into The Canada Gazette for 30 days, it can be missed. Things have been missed in the past. There needs to be a greater flag. I would have preferred to have had those amendments come to the parliamentary committee studying health related issues. That would have been a better step. My basic premise is that legislators should at least be involved. It should not be an almost behind the doors process. I will strongly state to anyone who will listen that the power to make regulations can be passed with virtually no public scrutiny. Powers delegated to the governor in council are broad, vague and border on dictatorial. Our subcommittee recommended that this be reviewed. I would like to hark back to the parliamentary secretary's comments when she said that the public scrutiny which is present today is just fine. Why would the government which controls this subcommittee agree to review if those powers are just fine? Those arguments are inconsistent. I am also very sceptical of the committee recommendation. I think that recommendation is going to fall into a black hole. I am going to give an example of why I think that will happen. The first duty in the health committee was to look at order in council appointments. I ask a question in the health committee that if we were going to review these order in council appointments, how many of them had been turned down in history. The answer was that members looked at me as if I were crazy. Surely the committee would not have the power to turn down an order in council appointment. I asked: ``Why are we doing it then? Strike a subcommittee on order in council appointments''. My premise was that the committee should review appointments at the appointment stage rather than at the nomination stage. Sure enough we have gone through a whole host of witnesses and the recommendation of the subcommittee was that order in council appointments, if they were to be reviewed by the committee, should be done at the appointment stage. There would be no power taken away from the government. If everyone on the list were up to snuff, there would be a checkmark beside each name. It would be a good time to review. Then the government could choose which individuals it wanted from those. (1255 ) I asked the question in high school class after high school class: If you were asked to review something, would you want to have that review be meaningful? The kids nod to me. We would think it was nonsense to do it any other way. Where has that recommendation that order in council appointments be referred to to the health committee gone? It has gone into a black hole somewhere, into government reorganization. That indicates to me how cynical the government process sometimes can be. If a group of high school kids can see that it makes sense, it surely must make sense to the legislators. I will watch with profound interest the recommendation from the committee to review this power to make regulations. If it falls into the black hole as well, I will be greatly disappointed. Bill C-7 has come a long way. If the power to make regulations were righted, I would support it. On the basis it is not righted, I will not support it. Mr. Paul Szabo (Mississauga South, Lib.): Mr. Speaker, it gives me great pleasure to speak on behalf of Bill C-7, an act respecting the control of certain drugs, their precursors and other substances, and to amend certain other acts and repeal the Narcotic Control Act in consequence thereof. 15955 This bill received first reading in February 1994 and passed second reading in April 1994. At that time it was referred to the House of Commons Standing Committee on Health which in turn struck an all-party subcommittee. I was appointed as the chair to study that bill, to receive witnesses from all parts of Canada representing major interest groups and to receive and consider submissions from major interest groups and Canadians from all walks of life. The committee received dozens of submissions and literally thousands of letters for its consideration. As a consequence of our consultation and discussions, a number of questions and concerns were raised. The committee took the interventions very seriously and requested answers and explanations from officials. The bill is the responsibility of the Minister of Health but numerous aspects relating to enforcement and justice matters necessarily involve the solicitor general's office and the Ministry of Justice. Officials from all of the ministries were very actively involved in the review of this bill after second reading and co-operated fully throughout the process. I want to give special thanks to them, particularly to Mr. Bruce Rowsell, director of dangerous drugs, health protection branch, Health Canada; Carol Langlois, project manager, bureau of dangerous drugs, health protection branch, Health Canada; G‚rard Normand, counsel, national security group, Department of Justice; Mr. Paul Saint-Denis, senior counsel, criminal law policy section, Department of Justice; and Ron Dykeman, senior policy analyst, policing and law enforcement in the solicitor general's office. The role of parliamentarians and their powers of influence as members of Parliament and members of standing committees of this House has changed dramatically in this Parliament. The subcommittee charged with the responsibility to study Bill C-7 demonstrated that the proposed legislation is subject to change. Indeed Bill C-7 has been changed in many important ways to address the legitimate concerns of Canadians. As a result of our work, the committee has sought amendments on a number of critical elements of the bill. I am pleased to inform the House that the government through its relevant ministries has brought forward substantive-I emphasize substantive-amendments which fully satisfy the concerns raised by the committee. Some of the areas relate to the whole aspect of rehabilitation and treatment: the issues raised by practitioners, particularly by the Canadian Medical Association; the integrity of needle exchange programs; confidentiality and access to information; the scheduling and particularly the criteria for scheduling of products; the aspect of criminal records; the issue of fortified drug houses. (1300 ) I could tell members that one of my colleagues from Edmonton came before the committee and made a plea on behalf of the law enforcement agencies of Edmonton to advise us of what is called fortified drug houses. Very briefly, fortified drug houses are dwellings that have been altered substantially to ensure that enforcement agencies would not get ready access in the event that they have determined that there were illegal or illicit activities transpiring within that dwelling. Initially, the bill could not address that. Reasons were given but the committee did not accept them. Thanks to the intervention of our colleague and member for Edmonton West, this bill now provides the mechanism necessary for our law enforcement agencies to deal with the serious problem of fortified drug houses. We also dealt with some complex matters to do with hybrid trafficking offences. I can tell members that the bill has changed significantly since second reading with regard to the amounts and the penalties. As has been mentioned, we dealt with the deeming provisions under section 3.1 which I will speak to more fully a little later. We also dealt with section 59, the administration procedure for adjudication, a very important section. Very briefly, the work of the committee was quite extensive, quite broad on a number of fronts. I am pleased to inform the House that the bill, as amended, received the support of all parties. Some 69 amendments were made to a bill that contains 56 pages, 94 clauses and a large number of schedules listing drugs and various other aspects. We believe that we have returned to the House a better piece of legislation which effectively meets the intended objectives of Bill C-7. The subcommittee actually went beyond its mandate to address Bill C-7. Not only did we discharge our responsibilities with regard to the bill as was directed by the Standing Committee on Health, but we also made a further report to the Standing Committee on Health putting forward certain recommendations flowing from the work we did in considering the provisions of Bill C-7. In brief, I would like to outline what those additional recommendations were. The first recommendation was that an expert task force be formed to devise rational criteria for schedules 1 to 7 of the control of drugs and substances act. We would like to see this task force include the assistance and the consultation from organizations such as the Addiction Research Foundation, the Canadian Centre for Substance Abuse, the Canadian Pharmaceutical Association, the Canadian Medical Association and the Canadian Foundation on Drug Policy, not to mention the Canadian Medical Association, particularly, and any other relevant bodies. We would like them to form a special task force 15956 with a mandate to establish precise criteria for the scheduling of substances under this act. As a number of speakers will mention in speaking to the bill today, it deals with a large number of drugs. As was dealt with in the report stage motion with regard to governor in council changes to regulations, as members will see, it is quite an onerous task to deal with the changes that would have to occur to scheduling if we have to go through committee every time a certain drug arises. The second recommendation has to do with Canada's drug policy. I am going to talk quite a bit about drug policy because I believe that Canadians should understand more fully the intent and the rationale for Bill C-7 and how it relates to Canada's drug policy, indeed the Canadian drug strategy. The subcommittee on Bill C-7 recommends that the House of Commons Standing Committee on Health undertake a comprehensive review of the existing drug policy. I am pleased to report that the Minister of Health has already informally given her concurrence that a comprehensive review of our drug policy should be conducted. (1305) The final recommendation has to do with the motion that was moved at report stage by the member for Macleod. It deals with the scrutiny of regulations and orders made by governor in council. This motion, in fact an amendment, was dealt with at subcommittee. Based on the conversations we had with all members and the debate that was held, it was clear that the question being raised was not generally relevant only to Bill C-7, but rather a matter of principle. A number of the previous speakers have referred to that principle: what can this place do and what authorities can it second in terms of amendments to legislation. The Parliamentary Secretary to the Minister of Health outlined very clearly that there is a mechanism in place for the exposure of changes proposed, whether they be regulations or other changes. More important, those changes are not substantive changes to the legislation and to the intent of the legislation. It is more important that those governor in council authorities be available so that changes can be made which are consequential to other changes that occur and that things can happen quickly. I will comment a little later, particularly with regard to section 3.1, the deeming provision, on new drugs and the reason why we have to pursue avenues to be able to address new drugs as they come on line. It has to do with technology and it has to do with the sophistication of those that produce illicit drugs. We have asked the Standing Committee on Health to direct a question to the government House leader whether the House of Commons standing committees could have the authority to approve or at least to review all relevant regulations or orders made by the governor in council prior to coming in force. I believe that recommendation satisfies the member for Macleod. He withdrew the amendment at subcommittee and supported the principle of assessing whether or not governor in council orders are being abused. It is a valid question and that is why the committee agreed with the member for Macleod to pose the question to the government House leader, so that all members of Parliament could more fully understand the mechanics and the rationale for governor in council orders. We believe that all committees should make appropriate recommendations consequential to the work they have done in studying legislation on what they have heard from the people of Canada. I am very proud that this committee took on itself to produce a supplementary report to the bill, which I feel is going to add substantially to the role of parliamentarians. I wish to move more specifically to the bill. The parliamentary secretary very eloquently outlined a number of the technical aspects of the bill. I want to go back to the genesis because I know that for many members on all sides of the House their first exposure to this bill was the old Bill C-85 from the former government. It is a draconian Mulroney bill. It is time for us to move away from the partisan apprehension about certain legislation because there are important reasons for Bill C-7 to be before this place and to be passed by this House. Bill C-7 forms part of the national drug strategy. It is a multi-year program set up to combat the illicit drug trade within our boundaries. The bill consolidates and supplements the provisions found in the Narcotics Control Act and Parts III and IV of the Food and Drugs Act. The supplementary provisions are necessary for a very important reason and that is because Canada must pass certain changes to its drug legislation so that we can be in conformity with certain international obligations to which we are a party. Those treaties are three. The first is the Convention on Narcotic Drugs of 1961. That treaty dealt with things such as the cultivation of the coca bush. (1310 ) The second treaty was the Convention on Psychotropic Substances, dated 1971. Among other things, it dealt with the expanded control over amphetamines. Finally, the so-called Vienna convention, is the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotro- 15957 pic Substances, dated 1988. Among other things, it deals with the import and export control over precursors. Why is Bill C-7 so important? That is a question which members of Parliament must understand for their own edification because of the concerns which have been raised at second reading and throughout the genesis of the bill. Because Bill C-7 provides for the scheduling of drugs which are controlled or restricted, it attracted substantial attention from groups and individuals who wanted to address Canada's drug policy with a view to taking a softer stance on drug possession and use and to treat it as a health problem rather than a criminal problem. This was the argument. Our drug policy is reflected in Canada's drug strategy. Seventy per cent of our spending is directed at rehabilitation and treatment alternatives. Bill C-7 is part of Canada's drug strategy and addresses the enforcement aspects of our drug policy. Many of the witnesses and interveners were critical of Bill C-7 because they wanted the opportunity to fully debate the overall drug policy, of which Bill C-7 is simply a part. Their interests were beyond the purview of our subcommittee but their concerns were noted in our recommendations which I referred to earlier. The most important rationale for Bill C-7 was to bring our drug laws into compliance with the international conventions to which we are a party. It is this aspect on which I would like to elaborate. Canada has been in violation of its treaty obligations for many years. As such, it has increasingly come under criticism by its treaty partners and the International Narcotics Control Board. This is the first time that a jurisdictional body has mentioned, so I would like to highlight the International Narcotics Control Board. Over the past 80 years a worldwide system to control drugs subject to abuse has developed gradually through adoption of a series of international treaties. The key multilateral conventions concurrently in effect are, as I mentioned: the 1961 single convention on narcotic drugs which was modified by the 1972 protocol; the 1971 convention on psychotropic substances; and the United Nations convention against illicit traffic in narcotic drugs and psychotropic substances, which was adopted in 1988. Each of these treaties has built on regulations already in place and has advanced international law. From the beginning the principal objective of drug control treaties has been to restrict the use of these drugs to medical and scientific purposes. The International Narcotics Control Board, known as the INCB, is an independent and quasi-judiciary body mandated to apply the United Nations conventions on drugs. It was created in 1968 by the 1961 single convention on narcotic drugs. Its predecessors were created by previous conventions on drugs, dating back to the League of Nations. The board is responsible for promoting the application of drug control treaties by government. These treaties set out its tasks, which are essentially of two types. First, with respect to the legal manufacture, trade and sale of drugs, the board ensures that there are sufficient quantities available for medical and scientific purposes and that none are misdirected from legal sources to illegal trafficking. To that end, it administers a narcotics evaluation system and a system of voluntary evaluation of psychotropic substances and monitors international drug trading through a statistical reporting system. Moreover, it monitors the measures taken by governments to control chemical products that can be used in illicit manufacture of drugs, assisting them in preventing their being channelled toward illicit trafficking. (1315) The second area of the mandate is with respect to the illicit manufacture and trafficking of drugs. In this regard, the board detects weaknesses in national and international control systems and helps to improve the situation. As well, it is responsible for assessing what chemical products used for illicit drug manufacturing might be placed under international control. Our failure to comply, particularly in the area of control of benzodiazepines, was clearly singled out in the 1994 report of the International Narcotics Control Board presented to the United Nations on February 27, 1995. I would like to refer to that report of the International Narcotics Control Board for 1994 to the United Nations. I want to quote from this report because I want for once and for all to demonstrate clearly to all members why it is so important that Bill C-7 is passed by this House. Paragraph 89 states: ``A few parties to the 1971 convention, including Canada, Luxembourg, and New Zealand, do not yet control international trade in all benzodiazepines. This represents a violation of the treaty obligations under the 1971 convention. The board has been in communication with those countries for a number of years, but their response has thus far been insufficient. The board reiterates its request to those countries to begin controlling without further delay their imports and exports of all benzodiazipines listed in the 1971 convention.'' The report further states in paragraph 180: ``Although Canada ratified the 1971 convention in 1988 and the 1988 conventions in 1990, national legislation is not yet in conformity with some of the provisions of those conventions and the Canadian authorities have not been fully implementing those provisions. There are indications that Canada is a source of benzodiazepines entering the rest of North America.'' 15958 Paragraph 182 states: ``In Canada, organized gangs trafficking in metamphetimines, PCPs, and lysergic acid diethlamide, known as LSD, are increasingly becoming involved in illicit trafficking in precursors and other chemicals.'' The final reference comes in the appending news release issued in conjunction with the INCB report. It states: ``The black market in the United States is another main target for diversion and smuggling of benzodiazepines. Canada, where imports and exports of these substances are not yet controlled, appears to be the main source of benzodiazepines diverted in the region. In one such case a broker company in the Bahamas established as a front by drug traffickers obtained from 1992 to 1994 large quantities of diazepam tablets from a Canadian origin to a local wholesaler. The company claimed that the tablets were to be exported to other countries in the Caribbean. In fact they were smuggled into the United States.'' There are a number of other references. I think all members would understand clearly that Canada has been embarrassed in front of the United Nations, through the World Health Organization, through the International Narcotics Control Board, because we have not met our obligations under the international treaties to which we are a party. Bill C-7, once passed, will in fact bring Canada's laws up to date and in fact satisfy all the provisions of those treaties to which we are a party. (1320 ) In March 1995 I had an opportunity, along with the parliamentary secretary for the Minister of Health, to meet with representatives of the INCB to discuss our deficiencies and to review the progress of Bill C-7. I am pleased to advise that they were satisfied that Canada had finally developed a piece of legislation that was going to address those concerns. We are looking forward very much to advising our treaty partners that our laws are now in order with regard to those treaties. That is the most important reason for this piece of legislation. Finally, I would like to make some brief comments about certain issues that attracted substantial attention throughout the subcommittee's work. The first issue, which I think has been on the minds of a number of members on all sides of this House, is our approach to illicit drugs. Many criticized Bill C-7 initially because they alleged that it reaffirms a criminalization and interdiction approach to illicit drugs instead of a public health approach. As I mentioned, Bill C-7 forms only part of Canada's drug strategy, under which 70 per cent of our efforts are indeed directed at rehabilitation and treatment as alternatives. Bill C-7 also now includes, which it did not at second reading, a specific section addressing and promoting a rehabilitation and treatment approach to illicit drugs. Bill C-41, the omnibus sentencing bill, also makes reference and encouragement to the courts and provides that alternative to the court system to ensure that wherever possible and appropriate, rehabilitation and treatment are desirable. Some also argue that a softer approach should be taken on illicit drugs because they cause fewer health problems than alcohol and tobacco, which were omitted from the bill. Alcohol and tobacco are no longer omitted from Bill C-7. If we are to be successful in taking a hard line on their use under our laws, we cannot get soft on drugs. Health impacts are not the only consideration. Far too many lives have been ruined by drugs, which costs our system billions of dollars annually in health, social, and justice programs. We will continue to work with our treaty partners in the World Health Organization, the UN, and the INCB to fight the war on drugs. An awful lot has been said today with regard to subclause 3(1), which has to do with a deeming provision. In simple terms, it basically states that if a drug or a substance is the same as or similar to an illicit substance, it would be deemed to be covered by the act. The member for Macleod and some other speakers tended to paint one picture. I would like to provide a different version of the realities having to do with subclause 3(1). The subcommittee and members of Parliament were literally swamped with letters and petitions from the distributors and users of natural and herbal remedies, as was stated by the member for Macleod. Industry leaders were alarmed because the bill referred to substances that had a similar stimulant or depressant effect to listed substances but were not themselves listed. All products sold to the public through natural and herbal remedy outlets have been approved for use in Canada under our existing laws and jurisdictional authorities. The effect of these substances we are talking about is so minuscule relative to the potency of the drugs covered by this bill that there was never any interest or intent to even mention herbal remedies and products such as camomile tea or ma huang. These are very mild stimulants or depressants, many of which are included in everyday cough syrup. There was never intent in the bill. In fact, there is a very important reason why the bill initially attempted to deal with unnamed or unknown substances. (1325) For those who have a need and a desire to use natural and herbal remedies, I say that if they can be obtained legally before Bill C-7, they will still be obtainable after Bill C-7 passes. The bill does not affect those. I do want to comment on the misinformation that was generated by certain parties with regard to subclause 3(1). We have received some 4,000 letters and petitions from people with regard to this. I saw the trade magazines, which stated and showed very clearly that if the bill passes stores will be closed and remedies will only be available from a doctor. They stated that these remedies will all be illegal and will never be available again. With 4,000 Canadians being driven to write to the committee, and I do not know how 15959 many wrote to other members of Parliament, imagine the alarm that was raised because of this misinformation. I wonder how much the industry had to do with trying to raise this concern simply for business reasons so that people would go out and stock up on these products. There was absolutely no basis for concern. I believe that kind of approach to political opportunism is totally inappropriate when we are dealing with the people of Canada on matters that are important to them. Subclause 3(1) was intended to cover substances that were chemically very similar to listed substances and produce the same or similar effect but were not themselves listed. The rapid changes in the technology of drug production makes it necessary for us to respond quickly to new drugs. If new drugs are to be developed and they are chemically very close and not on the schedule, it will take a long time to get them on the schedule and covered by the legislation. Governor in council orders allow at least a period of approximately 30 days to get something on a schedule. As the parliamentary secretary pointed out, if there were international implications or feedback or input had to be received from outside the country, that I believe would be extended to 75 days. Those are the reasons we need this. Although the provisions of subclause 3(1) would have been helpful, there was sufficient concern within the committee about the violation of a fundamental legal principle that requires that conduct that is subject to criminal sanction must be specified clearly in the act. This is the reason why subclause 3(1) had to be removed. Deeming a provision and saying it was the same or similar did not name a substance, and it was potentially going to cause a problem. The provision was dropped from the current bill, although I suspect it will have to be reconsidered should problems arise with new drugs arriving on the streets of Canada. Very briefly, the commercial production of hemp was raised with the committee. Substantial lobbying was done to have Bill C-7 permit the commercial production of hemp. Given the time I have, I would simply indicate to those who are interested that this particular bill does not at present permit the commercial production of hemp. There is a window whereby if it were deemed appropriate a mechanism could be triggered. However, this process could take years. I would simply say with regard to the commercial production of hemp that it is a long way off, if indeed it is appropriate at all. Finally, I want to comment on the subject of marijuana. Not surprisingly, a number of Canadians urged the committee to decriminalize marijuana. They argued that the penalties were too harsh and did not reflect the attitudes of most Canadians or the lenient practices of the courts or the police. (1330) No evidence was presented to us on the attitudes of Canadians. Not dealing with the drug policy in our committee, none was asked for as well. However, there is no disputing the courts were clogged. This bill deals with that by changing the process for simple summary convictions for simple or first time possession. There is fast tracking for dealing with those offences. The bill, passed by the House at second reading, included a provision that simple possession of cannabis was a criminal offence. As such, any proposal to decriminalize marijuana would have been ruled out of order. The committee could not even have dealt with the question because it was a change in drug policy. This committee had no mandate to deal with drug policy. The issue is one of drug policy. More important, under the provisions of the various international treaties to which Canada is a party marijuana possession must be a criminal offence. As such it is very unlikely Canada will consider such a change. A recent article in the Telegraph Journal in New Brunswick reported: ``For possession of small amounts of cannabis, the amended sentence is six months and a $1,000 fine instead of seven years and a $2,000 fine''. That simply is not true. It is misinformation and may lead the reader to believe the bill proposes the law to be more lenient on simple possession. Under the existing Narcotic Control Act the maximum penalty for simple possession of marijuana on first offence and by summary conviction is $1,000 and six months imprisonment. That is the existing law. Under Bill C-7 the penalty is identical, no change. We did not deal with drug policy. Attitudes of many Canadians toward marijuana were developed many years ago when many failed to realize the technology of breeding plants has allowed producers to drastically increase the potency of marijuana by increasing its THC content, tetrahydrocannabinol. Marijuana is about 15 times more potent today than it was 10 years ago. Marijuana today is as potent as cocaine was 10 years ago. Let there be no confusion, marijuana is a dangerous drug which can have serious health impacts. Its possession or use even in small amounts continues to constitute a criminal offence in Bill C-7 and in the laws of Canada. I thank the members of the subcommittee for their due care and diligence in addressing Bill C-7. I believe we have made a better 15960 piece of legislation and demonstrated once again that all members have the opportunity to significantly influence the development of effective legislation for Canada, which as we all know includes Quebec. The Acting Speaker (Mr. Kilger): We will now proceed to the next stage of debate in which members will be entitled to a 20-minute maximum subject to 10 minutes of questions or comments. Hon. Roger Simmons (Burin-St. George's, Lib.): Mr. Speaker, I am very pleased to rise in support of this bill. Like its predecessor, Bill C-85, this bill is intended to improve and modernize the drug abuse provisions currently contained in the Narcotic Control Act and the Food and Drugs Act. I believe all of us here recognize the need for some reform in this area. Parts of the legislation are more than three decades old. It is obvious we cannot fight the drug problems of the 1990s with 30-year old legislation. Some members have raised concerns about various aspects of the bill, particularly the health provisions which constitute the major part of the bill. Maybe those members are not aware that many of the concerns they have expressed have already been addressed by changes incorporated in Bill C-85 last year. Although it is for the Minister of Health to respond to those concerns which have not yet been addressed, it is necessary to emphasize two points regarding the health provisions before I turn to the smaller but important law enforcement component of this bill. This bill must not be looked at in isolation. It is not a standalone piece of legislation. It is the last and most important in a series of pieces of legislation designed to support the Canada drug strategy. (1335) This federal program is a ten-year, $480 million campaign launched back in 1987 to fight substance abuse and drug trafficking in Canada. As part of that strategy Bill C-7 is an important element of the government's overall campaign to curb substance abuse. Some members have raised alarming images of innocent doctors and pharmacists unable to practise their professions, of violations of doctor-patient confidentiality and of the potential for law abiding citizens to be prosecuted for the use of everyday substances such as caffeine. Of course nothing could be further from the truth. I believe that even the members who mouth that kind of fear know they are engaging more in fear mongering than in fact dissemination. The initial health regulations to be proposed under this new bill will be identical in effect to those which currently exist under the Narcotic Control Act and parts III and IV of the Food and Drugs Act. Further, all of these existing regulations were developed in close co-operation with the people they most affect, the doctors, the pharmacists and the veterinarians. We are not reinventing the wheel, we are simply building on a solid and proven foundation with the advice of the people most directly concerned. The bill would eliminate ambiguity and broaden the scope of existing legislation so that governments and police services can respond effectively to the Canadian drug scene of the nineties. Undoubtedly new health regulations will eventually be promulgated but not before they have been developed in full consultation with the people most directly involved. That can hardly be described as acting in haste or with lack of forethought. This is simply acting with common sense. The same common sense has been applied to the police enforcement aspect of the bill. Any police officer on the street will tell us that drug traffickers today use increasingly sophisticated methods to evade police efforts aimed at halting their deadly trade. To keep up with the traffickers the police need equally sophisticated investigative techniques such as reverse sting or sell-bust operations. I hope my friend from Edmonton is getting all of this. Mr. Hanrahan: You are going slow enough, Roger. Mr. Simmons: Good to see you. We meet here every day at the same time. The Acting Speaker (Mr. Kilger): I certainly do not want to diminish the friendliness that arises in the Chamber through debate but I urge members to please direct their interventions through the Chair. Mr. Simmons: I thought I had done so, Mr. Speaker. If I did not, I apologize. I believe I was referring to my friend from Edmonton in the third person. During this type of sting operation it is frequently necessary for the police to sell small quantities of drugs to traffickers to establish credibility and further investigations. These techniques already exist but at present have no specific legislative basis and consequently are open to legal challenge. The bill would ensure the police have an appropriate statutory basis on which to mount operations against drug traffickers in a manner consistent with the Canadian Charter of Rights and Freedoms. I know an hon. member has argued such authority already exists for all police services under section 18 of the RCMP act and he asked why we need this new provision. The answer is simple. First, section 18 of the RCMP act applies only to the RCMP and not to any other police service. Second, section 18 of the act does not provide a clear statutory authority to the RCMP for mounting undercover drug operations. (1340) It only imposes a duty on the RCMP alone to enforce the law using powers that already exist under other statutes such as the Narcotic Control Act. Clearly there is a world of difference 15961 between this broad statutory obligation and similar obligations in provincial police acts and the specific authority needed by all police services, federal, provincial and municipal, to carry out sting operations, an authority provided for in this bill. It is also important to note that the police enforcement regulations contemplated in this bill build on the existing narcotic control regulations and the food and drugs regulations. Both sets of regulations authorize police officers to possess narcotic and restricted drugs when directly related to police work. What is new is that the bill removes ambiguity that exists in the current legislation and gives police services a firm and clear statutory base for carrying out undercover drug operations. Again, we are not acting in haste here. The text of new police enforcement regulations have been published in the Canada Gazette, part I, to allow time for consultation and comment from all interested parties. Consistent with this, I am also pleased to announce that the solicitor general has provided to his provincial and territorial colleagues a discussion paper on the enforcement provisions of Bill C-7. This paper was also made public to members of the House and to the public. The paper outlines the policy underlying the new police enforcement regulations that will be made pursuant to this act. Again, this is an example of a government committed to consultation and the careful and methodical development of legislation that answers the needs and concerns of all stakeholders. That is how the government does business and how it should do business. There have also been concerns that Bill C-7 may permit an unwarranted intrusion by the federal government into provincial areas of jurisdiction, in this case the conduct of provincial and municipal police anti-drug operations. That concern is without foundation. Bill C-7 expressly recognizes that both the federal and provincial governments have clearly defined jurisdictions in the area of drug enforcement. The authority of the provincial ministers responsible for policing over provincial and municipal police services is expressly stated in the bill. Domestic issues aside, the bill is also important in that it will allow us to fulfil our international obligations. Canada is, after all, a signatory to three UN international conventions designed to counter substance abuse and drug trafficking: the single convention on narcotics drugs, a convention on psychotropic substances and the convention against illicit traffic in narcotic drugs substances. These international conventions are crucial in the fight against drug traffickers. Drug trafficking is an international problem requiring international action. We need only look at reports such as the RCMP national drug intelligence estimate to realize how true that statement is. Money laundering through international banking systems, illegal drug routes criss-crossing the entire world and drug production centres ranging from South America to the Middle East all emphasize that international co-operation and co-ordination are necessary to effectively fight drug trafficking. That is why it is important Canada fulfil its international obligations to the best of its ability. The bill will give our police services the tools they need to do their jobs properly and to ensure they are at least as effective in their anti-drug operations as their counterparts in other countries. Aside from providing the police with a statutory basis for carrying out undercover drug operations, the bill also provides three other measures that will assist the police in their anti-drug activities. First, the bill will provide for controls on the import, export, production and distribution of controlled substances while at the same time allowing for the use of substances for medical, scientific and industrial purposes. (1345 ) Second, the bill will provide a control on the import and export of precursors, which are chemical substances used to produce controlled substances. Third, the bill will provide for the forfeiture of any property used to commit such offences and for a comprehensive search and seizure mechanism consistent with the Canadian Charter of Rights and Freedoms. I hope in my remarks during the past few minutes that I have made it clear the police enforcement provisions of Bill C-7 are a carefully considered set of measures designed to give police the powers they need to do their job properly. The provisions do not embody any new and exceptional powers, contrary to what has been suggested in the Chamber. The provisions do not infringe on provincial jurisdiction, contrary to what has been suggested during the course of the debate. The provisions are subject to consultation and review. They balance the needs of the police against the interest of the community as a whole. In short, it is modern legislation designed to respond to the demands of a modern world. Our police services deserve all the support we can give them, particularly when it comes to fighting drug traffickers. In the past we have shown our support through the passage of the proceeds of crime amendment and the Seized and Restrained Assets Management Act. Speedy passage of Bill C-7, the Controlled Drugs and Substances Act, would both complement the previous two pieces of legislation I have mentioned and be a further demonstration of our commitment to support the police in their fight against the drug trade. Therefore I have much pleasure in inviting my colleagues on all sides of the Chamber to give their unfettered support to this excellent piece of legislation as expeditiously as possible. 15962 Mrs. Rose-Marie Ur (Lambton-Middlesex, Lib.): Mr. Speaker, it gives me great pleasure today to address Bill C-7. The problem of addiction and those who profit from addiction troubles the nation, my constituents in Lambton-Middlesex and people throughout Canada. Speaking as one who was elected to represent the same constituents, it troubles me. The illicit drug trade and those who live off its avail exact a heavy toll, especially on that segment of our population at the greatest risk: our youngsters, a prime and favourite target of those dealing in illicit drugs. Drugs destroy families. They destroy careers and they destroy futures. They also destroy young lives. Perhaps most of all, whilst doing so they put cash into the hands of criminals. In the early eighties there were more casual drug users among young people. While we see today a steady decline of casual drug use, there remains a hard core group of heavy drug users. What is worse is that those who make up the majority of the group are the youngsters hardest to reach. Street youth today are consuming far more drugs than frequent drug users who are still in school. The battle against illicit drug use is being waged in our cities, where the problem is most visible, through programs and high profile media campaigns. It has also been carried out in smaller communities across the country. Do we need more compelling reasons to advance the case against drug abuse? These people, the young, the abused, school dropouts, street kids, the unemployed and off reserve aboriginal youth are hard to reach. (1350 ) It therefore follows that the critical path to addressing the issues of substance abuse lies in education, prevention, treatment and rehabilitation. We must also strike at the root of the problem. We must equip law enforcement professionals with the tools needed to deal effectively with those who prey on the addicted. This bill provides the tool. We must promote sound law enforcement if we are ever to advance in the broader social goal of maintaining safe and peaceful communities. The bill provides the means of accomplishing this goal. We have also heard how the bill looks to the future. First, it provides for flexible framework for controlling the import, export, production, distribution and use of controlled substances. Second, it provides a mechanism that will allow us to implement our international obligations and to restrict the production or trade of regulated substances to the medical, scientific and industrial purposes. Third, it enhances enforcement of the law by the police and the courts as it provides the police with the necessary tools to enforce the law and provides for the seizure and forfeiture of property used in offences involving controlled substances. Additionally, by reaching a broader range of controlled substances, the new legislation will help make it more difficult for drug dealers to reach children and will strengthen sentences handed down by the courts. It will make it easier for the police to arrest people who deal in illegal drugs. Drug dealing in and around schools and in or near public places usually frequented by minors will constitute an aggravated factor at the time of sentencing. This means that judges will have to justify their decision when not imposing a jail sentence. The new bill also places safeguards at all levels of production and distribution of controlled substances. This should ensure that they are not diverted from medical, scientific and industrial channels to the illegal street market. Right now as we debate the bill designer drugs are being produced in some clandestine laboratory and cannot be subjected to prosecution until they are included in the schedules. These designer drugs have the same basic properties as more familiar substances such as stimulants, tranquillizers and painkillers. However their chemical properties have been slightly altered. The result is that these substances are not covered by existing legislation and can be sold with impunity. Under the bill law enforcement officials will no longer have to wait for the drugs to appear on statutory schedules to stop criminals from selling them. So-called precursors, legal substances used in the manufacture of illicit substances, can also be obtained in large enough quantities through devious means. The bill contains enhanced controls for anabolic steroids. Studies in the United States and Canada have shown clearly that the problem of steroids is not confined to the high stake arenas of international competition. This was confirmed by Justice Dubin's findings. High school and college athletes use steroids in hopes of winning athletic scholarships or to shape up more quickly. Recreational athletes, adolescents and adults alike use steroids to improve their physique. It is no secret that even taken in limited doses for legitimate medical purposes steroids can cause serious side effects. Information from law enforcement agencies suggest that most steroids used by athletes are not prescribed by physicians. The mixture sold on the street may be of inferior quality or could pose unknown health risks. Under the proposed act not only will it be easier to arrest and convict traffickers but it will enable governments to seize and forfeit the proceeds of crime and property used or intended for the purpose of committing a drug related crime. 15963 It is only through the adoption of the measures of education, prevention and law enforcement that we will have the necessary means to foster healthy communities free of addiction, degradation and criminal oppression. Children are entitled to grow up and develop in a supportive and caring environment, one which spawns honest, healthy and productive lifestyles. The bill before us is one way we can help to promote such a climate for the children of Canada. (1355) At this point I stress three particular concerns brought to the attention of the subcommittee during its study of Bill C-7 with respect to the definition of practitioner. A number of witnesses appearing before the subcommittee, in particular the Canadian Medical Association, had grave concerns. We have addressed those concerns by setting out the definition of practitioner in clause 2 and by specifying that a practitioner be a registered and licensed individual. We have removed any possibility of the regulated activities of professionals being equated with trafficking. The next issue is subclause 3(1) as originally drafted in the bill that deals with the effect similarity of substances not covered in any of the bill's schedules. Concerns over the particular subclause were raised by many groups and individuals. Their perception was that certain herbal products might be inadvertently covered by it. Because of these concerns the subcommittee agreed to delete subclauses 3(1)(a) and (b) entirely. Essentially the effect similarity provisions have disappeared and we believe this would definitely erase all concerns regarding herbal products. I will respond to some criticisms raised by members of the opposition during debate at second reading. Both the official opposition and Reform members identified the absence of regulations as a fundamental impediment to obtaining a full zzyzThe Speaker: The member will have time left in the debate after question period. However, it being 2 p.m., we will now proceed to Statements by Members. ______________________________ 15976 GOVERNMENT ORDERS [English] CONTROLLED DRUGS AND SUBSTANCES ACT The House resumed consideration of the motion that Bill C-7, an act respecting the control of certain drugs, their precursors and 15977 other substances and to amend certain other acts and repeal the Narcotic Control Act in consequence thereof, be read the third time and passed. The Speaker: The hon. member for Lambton-Middlesex has about 10 minutes left in her speech. Mrs. Rose-Marie Ur (Lambton-Middlesex, Lib.): Mr. Speaker, the regulations made initially under the new legislation will not differ substantially from those that currently apply to such activities under the existing legislation. One of the purposes of the regulation making power is to enable the government to respond quickly to changing professional practices. The flexibility provided by regulations will ensure the availability of such drugs for appropriate medical and scientific purposes while complying with international drug control conventions. Any changes in the regulations will only be made following full consultation with all affected parties using a regulatory consultation process that has been used for years by the Department of Health. Both the official opposition and the Reform Party member suggested there would be inconsistencies between various provisions of the bill and the charter of rights and freedoms. One of the aspects of the bill identified as giving rise to charter challenges relates to the powers of inspectors under part IV. Reference was made to the interim order provisions of section 34 which permit the Minister of Health to act to limit professional drug distribution activities where there is substantial risk of immediate danger to the health and safety of Canadians. In addition the requirement to answer an inspector's questions was equated with self-incrimination in a criminal context. In reply the solicitor general pointed out to members that the Minister of Justice must examine every bill for compliance with the charter before it is tabled. Inspections that we are referring to here are inspections conducted to determine whether regulated persons are complying with the requirements under which they carry on their business or their profession. There are many acts, both federal and provincial, which confer broad powers of entry on inspectors in the interest of ensuring public health and safety. (1515) These provisions are not criminal law in the true sense, but administrative provisions that either have an independent existence or are incidental to criminal law. The applicable charter principles are not those that apply to criminal law provisions, but those that apply to administrative inspection regimens. These types of provisions have been in force in Canada under federal drug control legislation for over 80 years. They effectively establish a federal regulatory scheme that governs the distribution and use of scheduled drugs in Canada in a manner consistent with limiting their diversion to the illicit drug market and consistent with Canada's international obligations under the United Nations drug control conventions currently in force in Canada. Contraventions of designated regulations give rise to a hearing before an adjudicator as indicated in part V of the bill. It may result in a ministerial order which should effectively prevent a reoccurrence. No penalty of fine or imprisonment applies to a breach of these provisions of the regulations. Charter principles that would apply if imprisonment were available as a penalty are not applicable here. Another area of criticism relates to the impact of the bill on physician-patient and pharmacist-patient confidentiality. Both members identified access to confidential files of patients as an unacceptable interference in the private lives of honest citizens. There is very little new here. For over 30 years, under the narcotic control regulations the Minister of Health has exercised legislative authority to require a practitioner to provide any information concerning a patient treated with narcotics to the bureau of dangerous drugs, including the diagnosis, history and prescribing information relevant to the patient. This is the very information inspectors are being authorized to copy. Similarly, pharmacists are required to report prescriptions every two months to the bureau of dangerous drugs. Approximately 4.2 million prescriptions are reported to the bureau each year. Subject to legitimate program activities required under the current and proposed legislation to protect public health and safety, physician-patient and pharmacist-patient confidentiality is and will be fully maintained. This information currently obtained is also subject to the Privacy Act, which prohibits its use or disclosure by any official except in accordance with that act. The Privacy Act ensures that all information collected by the federal government for program purposes is treated confidentially. Concerning the so-called doctor shopping or double doctoring offence, the official opposition member cited evidence given by the Canadian Medical Association before the legislative committee which examined Bill C-85. It was argued that Bill C-7 would be unsatisfactory to doctors as they would be included within the ambit of clause 5(2). The Reform member asserted that this provision would mean that seeking help for an addiction would be a crime. In fact, the criticism was accepted by the committee and it was proposed that the provision be changed to essentially return to the existing section found in the Narcotic Control Act. As a result, the provision now refers only to persons who receive prescriptions from doctors. 15978 The Reform member's comments are difficult to understand. Clause 5(2) of Bill C-7 as it now stands could not be applied to a person who goes in any one month to only one doctor for his medical requirements. This provision deals not with dependent persons seeking help, but rather with dependent persons who are seeking drugs from many doctors but help from none. We all understand that control of controlled substances is a complex matter which requires a carefully constructed legal basis in order to be effective, judicious and fair. I believe this bill is a most appropriate instrument for the administration of the laws and regulations we need. We are dealing with an aspect of society which demands proper protection of the innocent, the inexperienced and the vulnerable. It also demands forceful prosecution of the exploitive, the criminal and the ruthless. I believe this bill strikes just the right balance between these two requirements. (1520 ) While we continue to minimize harm through education and prevention, and while we continue to show compassion for victims through treatment and rehabilitation, we must also strike at the criminal heart of this problem. In passing this bill, we will be making contributions to successful battles against drug abuse now and well into the future. Mr. John Maloney (Erie, Lib.): Mr. Speaker, I welcome the opportunity to speak on this bill today. This bill concerns controlling drugs and substances and addresses one of the most compelling issues with which society is faced today, the issue of drug abuse. Constituents in Erie riding have demanded action and this government has responded. As each member of the House is only too aware, drug abuse and the untold suffering it causes knows no geography, no socioeconomic class, no social graces. The problem is widespread. It strikes hard and with devastation. It destroys families, careers and lives. We must stop this waste. According to a United Nations survey, trade in illegal drugs is second only to world trade in arms. This is a very sobering fact. The incidence of drug abuse rises considerably among teenagers and young adults who are school drop outs, unemployed, or homeless. Do not be fooled. This disease, this cancer is in our schools as well. Ask your children. Ask your grandchildren. It is truly frightening. While recognizing that there is a need to emphasize demand reduction, it is important that the Government of Canada complement these efforts with drug law enforcement and crime prevention. This bill is intended to consolidate, modernize, enhance and streamline the government's drug control policy underlying two current acts of Parliament and to fulfil Canada's obligations under three international conventions. In 1961 the government of the day enacted the Narcotic Control Act as a follow-up to the single convention on narcotic drugs. In anticipation of the 1971 convention on psychotropic substances, in 1961 and 1969, Parliament passed parts III and IV respectively of the Food and Drug Act. In essence, much of our existing legislation framework is now more than 30 years old and must be reviewed. It is for this reason among others that this legislation is necessary. Furthermore, as a signatory to three international agreements on the illegal drug trade, Canada is obligated to the terms of the single convention on narcotic drugs of 1961, the 1971 convention on psychotropic substances and the relevant parts of the 1988 United Nations convention against illicit traffic in narcotic drugs and psychoactive substances. Consequently, the controlled drugs and substances bill is designed to achieve three prime objectives. First is to provide the government with the flexibility required to better control the import, production, export, distribution and use of controlled substances. Second is to provide the mechanisms needed to implement our obligations under international agreements. This relates to the restricted production or trade of internationally regulated substances destined for medical, scientific and/or industrial purposes. Third is to enhance the ability of the police and the courts to enforce our laws. The bill provides for the seizure and forfeiture of property used in offences involving controlled substances. It also allows for the restraint and forfeiture of fortified drug houses. The use of fortified drug houses for the purposes of drug trafficking is an increasing problem. The houses are generally family dwellings that have been modified for use as centres for drug trafficking. They are veritable fortresses of crime. The houses are fortified by adding steel doors, boarding up windows and adding cement walls. In some instances, trap doors are used to exchange money and drugs so that there is no contact between the trafficker and the purchaser. The purpose for building such houses is to delay or prevent entry by police. During the extra time it takes the police to gain entry, any evidence of drug dealing is destroyed. The existing Narcotic Control Act and the Food and Drugs Act do not effectively deal with emerging trends in drug abuse. We must be able to adapt to rapidly changing criminal activity. These trends see the appearance of new illicit or new designer drugs which can escape effective control under current law. Their methods, their tactics and their products are forever undergoing change. We must respond and quickly. We need flexible legislation which 15979 allows those on the front lines of enforcement to adapt quickly to these new developments as they occur. (1525) For example, one of the more recent developments in the drug underworld is the production and illicit sale of so-called designer drugs. Designer drugs are potent substances with chemical structures slightly different from substances presently controlled by the Food and Drugs Act and the Narcotic Control Act, substances such as stimulants, tranquillizers and pain killers. Yet these drugs affect abusers in similar ways and can lead to the same health and social problems produced by more conventional drugs. Much harm can result from the abuse of these drugs. Primary targets are often school age children. The manufacture and sale of the designer drugs can be a very profitable business. Under the current Food and Drugs Act and the Narcotic Control Act drugs must first be listed on a schedule to the act. This regulates the conditions for the sale of that particular substance in Canada. Only once a given substance is listed can it become an offence to sell it. To correct this deficiency the controlled drugs and substances bill proposes the inclusion of analogues to cover these substances. Analogues are non-listed substances that have highly similar chemical structures to those of listed substances. Under the proposed act new illicit drugs appearing on the street which fit this description will be covered automatically. The bill also permits the control of precursors. Precursors are chemical substances used to produce controlled substances. New provisions contained in the bill will enable authorities to regulate the import and export of these substances. Other sources of drugs sold on the street are substances intended for medical or scientific use. They may be stolen from a hospital, obtained through illegal prescriptions, secured by obtaining numerous prescriptions from different doctors for the same ailment or via a forged prescription. People who deal in diverted pharmaceutical drugs are collecting very large profits. This bill enhances present controls that deal with this issue. Under this bill the monitoring of the distribution of drugs will continue. We know there exists a criminal element which is using more and more sophisticated networks to illegally produce, sell, export and import controlled substances in Canada. These people buy property and consumer goods to further their criminal activities and bolster their personal wealth. As I see it such people should be prevented from retaining illegally obtained capital and goods. The bill before us today in tandem with the proceeds of crime legislation strikes at the heart of criminal enterprises. Together the legislation will enable the courts to strip criminals of profits and property illegally amassed through drug dealing. Traffickers will no longer be able to flaunt their Rolex watches, fancy cars and mansions, flashy boats and planes, and rightfully so. Trends in illegal production, distribution and use of controlled substances change frequently and quickly. This bill is designed to deal with current problems and to anticipate future needs. This bill proposes a significant strengthening of our current legislative framework. Nonetheless I believe this bill merits the support of all members on all sides of the House. Given what is at stake, I submit Canadians expect no less of us. Ms. Bonnie Brown (Oakville-Milton, Lib.): Mr. Speaker, it is my pleasure today to speak on Bill C-7, the controlled drugs and substances bill. I would like to discuss for a few moments the rationale for this legislation, in effect why Canada needs this bill and why the government is appealing to members of this House to support it. The current situation the world faces regarding illicit drugs is unsettling. The problem of addiction and those who profit by addiction troubles the nation. It troubles my constituents and speaking as one who is elected to represent those same constituents, it troubles me. The bill is a major contribution to effective law enforcement and prosecution of offenders as it consolidates, enhances and modernizes current drug legislation. (1530) It is true in many communities that there has been some decline in drug abuse among the general population, but there are also some distressing trends. Some abusers are taking much more potent drugs and the results are very harmful. Others are using drugs in very dangerous combinations. There has been continuing inclination by youngsters to adopt the dangerous practice of taking anabolic steroids to try to build up their bodies. Unfortunately, prompted by constant and uncritical coverage in the media, uninformed people have come to abuse the drug without thinking of the consequences and equally unfortunately dealers have responded to this new demand. Abuse has now spread to gymnasiums and high schools, putting at risk the health of young men and women. As is common in drug dealing, the anabolic steroids may be adulterated, raising the risk even higher. The bill is designed to provide the government with improved means to prosecute people who deal illegally in anabolic steroids. It furnishes a framework to target purveyors of poison, the drug dealers who are the instruments of destruction of too many young citizens. 15980 Despite a gradual decline in the abuse of most drugs, there are several alarming trends emerging on the horizon. Many drugs which are abused today are extremely potent with more potentially damaging consequences. Abusers are consuming drugs by much more dangerous means and they are using drugs in more dangerous combinations. There is a growing frustration among law enforcement officials, community leaders from across the nation and Canadians in general. They are calling on provincial governments and the Government of Canada to assign a higher priority to dealing with drug abuse and its costly impact. Demands are being made for more severe sentences, a streamlining of the judicial system and assignment of the proceeds of drug crimes to help finance education and enforcement programs. Court delays and complexities of administering the law have only helped to fuel the public's growing concern. Some law enforcement agencies have declared that the costs of enforcing the law against drug dealers have become high. The government recognizes that these concerns require deliberate and sustained action, including combating the evil of addiction on three fronts: education and prevention, treatment and rehabilitation, and enforcement and control. Bill C-7 corrects the deficiencies of existing drug control legislation. It encompasses all listed substances and declares them illegal for other than legitimate medical, scientific or industrial use. In conjunction with the proceeds of crime legislation adopted in 1988 and proclaimed on January 1, 1989, the bill will empower the courts with the right to confiscate all property and capital accumulated as a result of or used in the commission of drug related crimes. This will provide police forces and the judiciary with the tools they need in a manner consistent with the charter of rights. With the bill Canada will fulfil its international obligations found under the 1961 single convention on narcotic drugs, the 1971 convention of psychotropic substances and an international treaty governing the trade of illicit drugs. The proposed bill can become an effective instrument in enforcing the law and controlling the import, export, production, sale, distribution and possession of illegal drugs. The bill seeks to update, enhance and consolidate a section of the Food and Drug Act and the Narcotic Control Act, both passed long ago in the sixties. While the whims and wants of society have become more and more sophisticated since that time, unfortunately so has the network of drug producers and dealers. (1535 ) The bill is designed to correct certain anomalies and shortcomings in our current law. In so doing it will enable law enforcement agencies to deal more effectively with a cunning, determined and resourceful adversary, the dealer in illicit drugs. The new main provisions of the bill include controls on the import and export of precursor chemicals used by drug manufacturers. These chemicals include substances, usually not themselves psychoactive, which criminals can change easily into illicit drugs. The bill also provides for provisions to control the production, sale, distribution, import and export of androgenic-anabolic steroids; provisions to control the possession, production, distribution, sale, import and export of designer drugs developed by dealers for the purpose of evading current laws; provisions to search, seize and have forfeited property used or intended for the purpose of committing drug offences, also known as offence related property including fortified drug houses. The bill also includes a complete scheme for obtaining search and seizure warrants; the expansion of offences concepts relating to trafficking and production; the enhancement of control over disposal of controlled substances including forfeiture; new provisions to control the possession, production, distribution, sale, import and export of designer drugs; provisions which will facilitate Canada's commitments under the international conventions; and treatment by the courts of drug dealing in and around schools and other public places frequented by children and dealing drugs to minors as aggravating factors at the time of sentencing. The principal purposes of the bill are to provide one comprehensive act for the drug control policy of the government and to provide for the enforcement and control aspects of Canada's drug strategy. I will review briefly the seven principal parts of the bill as well as the introduction. Part I sets out the offences and punishment commensurate with breaking the proposed new law. The particular offences may include possession, trafficking, importing and exporting, production, possession of property obtained as a result of certain offences, and the laundering of proceeds obtained as a result of certain offences. Part I also sets out specific aggravating factors to be considered by the court at the time of sentencing. These are directed particularly at drug dealers who target children, those who use weapons and violence, as well as those who have previous drug related convictions. This part also included a purpose clause dealing with sentences and, more particular, encouraging rehabilitation and treatment in appropriate circumstances. Part II deals with enforcement of the proposed act by police. This includes provisions relating to search, seizure and detention of property or illegal substances, forfeiture of offence related 15981 property, as well as a complete scheme for protecting innocent third party rights over such property and forfeiture of proceeds of drug related crimes. Part III outlines procedures for disposal of controlled substances. Part IV covers administration and compliance. There are seven parts to the bill and its most important provision is that it moves Canada 30 years in time from the sixties to the nineties. It codifies and empowers police while at the same time it protects citizens. It gives us a Controlled Drugs and Substances Act that has merit and is enforceable. The Speaker: Notice was given to another Speaker and I was just given a paper indicating that the member for Oakville-Milton is splitting her time with the hon. Parliamentary Secretary to the Prime Minister. The parliamentary secretary has approximately 9.5 minutes. Ms. Jean Augustine (Parliamentary Secretary to Prime Minister, Lib.): Mr. Speaker, I rise to speak on Bill C-7, a bill in which many in Etobicoke-Lakeshore have an interest. I am talking about individuals who work in the areas of education, prevention, rehabilitation, treatment, enforcement and control. Those individuals are very interested in the general types of control substances outlined in Bill C-7. (1540) Narcotics are covered under the Narcotic Control Act, as well as some from the 1961 single convention. Examples of drugs in this group are cocaine, opium, codeine, morphine and marijuana. Controlled drugs, as defined under the Food and Drugs Act, are stimulants such as amphetamines and sedatives such as barbituric acid. Restricted drugs come under the Food and Drugs Act, the so-called designer drugs, as well as the anabolic steroids, the precursors and the drugs from the 1971 convention on psychotropic substances. The majority of the substances are diverted from legitimate manufacturers and then illegally imported and sold. Until recently dealers have been able to sell the steroids at up to 20 times their prescription value with little risk of getting caught. The amendments to the Food and Drugs Act and its appended regulations contained in the bill have resulted in 42 androgenic-anabolic steroids and their derivatives being classified as controlled drugs. In the grim world of the effects of illicit drugs on the lives of abusers can be severe. This is the crux of my argument. If the effects on the lives of the abusers can be severe, the penalties proposed for convicted dealers in the most dangerous drugs should be severe. Sentences for the most serious offences of trafficking, importing or exporting narcotics remain life imprisonment in the bill. We know that the specific provisions of the bill have been given the close scrutiny they deserve by a subcommittee on Bill C-7 of the Standing Committee on Health. I will comment on the work of that committee. Members heard from many national groups and associations representing a community of thousands of people, as well as officials from the departments of health and justice. I will quickly list some of the groups that made representations before the committee: the Canadian Medical Association, the Canadian Pharmaceutical Association, the Canadian Association of Chiefs of Police, the Royal Canadian Mounted Police, the Canadian Centre on Substance Abuse, the Department of Public Health, the city of Toronto, the Addiction Research Foundation, the Canadian Bar Association, the Canadian Foundation for Drug Policy, Lambton Families in Action for Drug Education, the Quebec Bar Association and the Criminal Lawyers Association, et cetera. Many groups appeared before the subcommittee. The subcommittee fully addressed each and every concern with the intent of improving the bill before us today. Several amendments were made at committee stage. Some particular issues of discussion resulted in amendment. The main amendments to Bill C-7 are the ones in which my constituents are interested. The amendments create a new offence for possession of marijuana and hashish involving certain quantities. They create a new offence for trafficking in marijuana and hashish in certain quantities. They provide for a purpose clause dealing with sentences and, more particular, they encourage rehabilitation and treatment in appropriate circumstances. The aggravated circumstances section has been expanded to cover in or near public places usually frequented by minors. This means that when an offender has been convicted in those circumstances a judge will have to give reasons for not imposing a jail term. The amendments will delete subsection 3(1), which was meant to cover non-scheduled substances having or presented as having the same effect as scheduled substances. There were some apprehensions among other things that it might cover herbal products. At the same time there is a limit on the ability of inspectors to examine the records so that they may not examine the records pertaining to the medical condition of patients. (1545 ) The bill clarifies those situations where a practitioner would be considered to be trafficking by providing that unless authorized by the regulations it will be illegal to sell a prescription to obtain a scheduled substance. Several things have been done and several amendments have been made to the original Bill C-7. 15982 I am confident that the current situation facing Canada today as it relates to drug abuse will prompt each member of this place to consider the facts in his or her own constituency, to reflect on the implications for the future, and to respond accordingly by supporting this bill. Through education and prevention we must continue to inform our young people, alerting them to the seductive snares of addiction. Through rehabilitation and treatment we must reach out and free those already trapped in the nightmare of dependence and desolation. Through enforcement and control we must strive to disinter the roots of those criminal enterprises that prey on the young and defenceless, those who otherwise risk being enticed into a never-ending cycle of addiction and deprivation. The bill gives the police new authority without giving them sweeping authority. It gives us greater power to prevent dangerous substances from entering the country. It gives us the tools to help ensure that justly prosecuted criminals do not benefit from their crimes. I submit that passage of the controlled drugs and substances bill is but one step toward a healthier and safer tomorrow. It is nonetheless a very important step in the right direction. I urge all members from all sides of this House to give this bill the scrutiny it richly deserves. Anything less would be an abdication of our responsibility. Let us pass this bill so the government can get on with its mandate to protect and promote the health of Canadians in a way consistent with what we have a right to expect. I call on everyone to support this. Mr. Nelson Riis (Kamloops, NDP): Mr. Speaker, I have listened to some excellent presentations today on Bill C-7, an act respecting the control of certain drugs, their precursors, and other substances and to amend certain other acts and repeal the Narcotic Control Act in consequence thereof. On balance, I find myself in support of all the concerns raised. Members have pointed out some of the highlights of this legislation and its attractiveness. As the previous speaker has just mentioned, it is one step toward a healthier and safer tomorrow. On that there is no question. However, it does pose a more fundamental issue. Yes, this bill takes some steps to fight drug dealers in their pushing of illicit drugs and illicit substances of all kinds. Some time or other we have to have a debate that asks why so many people, particularly young people, are attracted by these illicit substances. What is it about their lives and the way they view the world that makes abusive substances such an attractive option? What are the causes of drug abuse? What are the causes that enable drug dealers and drug pushers to make such lucrative incomes in our country? That is the debate that is absent here. If we believe that passing legislation and getting tougher on drug dealers is going to solve this problem, we have to admit that it will not. Yes, indeed it is a step closer. Yes, we have to get tougher. I particularly like the section of the bill that refers to those traffickers and so on who are trafficking illicit substances in or near a school, on or near school grounds, or in or near any other public place usually frequented by persons under the age of 18 years. To say that those convicted who have been pushing their illicit drugs in and around schools will obviously receive a harsher sentence is an excellent start. However, I do have to say that until we as a Parliament start addressing the fundamental causes of drug abuse we are not going to solve the problem. I do not think we want to feel too good about ourselves, that passing this legislation is going to be a major step toward the elimination or reduction of the use of illicit drugs. As the previous speaker said, and I think very accurately, it is a small step in the right direction. (1550) I have two concerns about this legislation. One is the fact that once again we missed the opportunity to deal more effectively with marijuana and the use of marijuana. We all appreciate that this legislation began under the previous Mulroney administration and was brought forward by this administration with very few amendments at that point. At that point one of the hopes a lot of people had, particularly those involved with the court system and with the real world of illicit drugs and substances on our streets, was the possibility that marijuana would not be listed in the same penalty class as heroin and cocaine, that perhaps now was the time to follow the call from the police and so on in terms of the decriminalization of this substance. I am not saying the legalization; I am talking about the decriminalization. Alas, Bill C-7 continues the tradition of treating marijuana possession as a criminal offence. All of us have known probably on a personal basis friends and constituents who now possess criminal records for having had in their possession a small amount of marijuana. They are lumped into the same category in many cases with cocaine dealers and that problem element in our society. This was a missed opportunity. I want to make a few comments about the herbal remedies that were once a major part of this legislation. It is fair to say that increasingly Canadians are turning away from traditional medical systems and sources to more natural ways. The herbalists are coming into their element and coming into their time. People realize that many of the substances we use in the traditional pharmaceutical way are in fact derivatives of natural substances. Increasingly today physicians will say that many Canadians are taking advantage of natural herbs to solve some of their medical problems. 15983 The lobbying that went on by those involved in herbal medicine was quite astounding. I suspect all of us received numerous petitions and letters and visits from people who were concerned that this legislation in its previous state would have eliminated a whole set of possibilities that herbalists were using. I particularly refer as an example to Natural Way Herbs, headed up by Mr. Jim Strauss and his son, who led a tremendous campaign from the western part of Canada to point out to parliamentarians that many of the substances that were being eliminated under this legislation were in fact being used very successfully today to resolve people's medical problems. I can say that I am aware in a personal way of dozens and dozens of people who found the traditional, if you like, medical approach to their illnesses and physical problems were failing and yet found the solution in the use of natural herbs. I thank Mr. Jim Strauss and his son, seventh generation herbalists, for the contribution they make to their community and their patients. As a result of much of this positive lobbying, the herbal remedies continue to be regulated by the Food and Drugs Act. That was a good change in this legislation. I will leave it at that. It is appropriate that we get on with this legislation. For those two reasons, I will oppose the legislation. That is not to say that there are not a whole set of very positive elements in the legislation. I want to acknowledge that. But the hassle the natural herbalists experience today is partly as a result of lobbying by the traditional health care system and the international pharmaceutical companies. We have to be aware that there is a holistic approach to solving medical problems and that the natural way, the use of natural herbs, is one way. We ought to be taking more steps to encourage that, as opposed to hindering it. (1555 ) Ms. Hedy Fry (Parliamentary Secretary to Minister of Health, Lib.): Mr. Speaker, I would like to respond briefly to the two very important points the hon. member just made. One had to do with herbal remedies. It was the last one, so I will deal with it first. I will be very quick. There never was in Bill C-7 anything that impacted on the use of herbal remedies in health food stores. That was disinformation and misinformation, whichever way we want to look at it. The sale of herbal remedies in health food stores is dealt with in parts I and II of the Food and Drugs Act. This bill only deals with parts III and IV, so it never was going to impact on it. We removed that whole section because of so much disinformation and so much concern. We thought if we struck that whole clause it would in fact allay these fears. The second point the hon. member made was regarding the cause of young people using drugs. That is such a multifactorial question. It deals with so many other issues. As a result of that and as as result of looking toward that kind of broader prevention and long-term strategy, the hon. member should know that a recommendation came out of subcommittee to the Minister of Health asking that Canada's complete drug strategy be reviewed. This is obviously going to deal with some of those issues. I would be distressed if I thought the hon. member would withhold voting on what is a very important and a very creative and progressive bill for two reasons that actually I hope I have answered to his satisfaction, one of which will be dealt with and the other of which never existed at all. Mr. Riis: Mr. Speaker, I appreciate the member's response to my latter issue and I accept what she says as being accurate. Disinformation was prevalent across the country and caused undue alarm to a lot people unnecessarily. I am pleased she has pointed out how that was dealt with. However, I do not accept quite so easily her latter comments that there has been a recommendation to have a broader approach to combating drug abuse in our country. Perhaps the record will show that this is the crucible where critical debate takes place in Canada. This is the centre where government and on occasion opposition members through opposition days and perhaps even private members' initiatives bring forward the issues we feel are important. By and large, we acknowledge that the government sets the agenda for most of what goes on in this House. But I do not recall in all my years in Parliament ever having a debate on the fundamental causes of substance abuse in our country. In other words, yes, debate takes place on specific pieces of legislation, but I am talking about the fundamental causes of drug abuse, like poor housing opportunities, poor educational opportunities. We all know the causes, as opposed to the symptoms. I appreciate what my hon. friend is saying. I do look forward to a time when we say to ourselves in this country that passing legislation, imposing stiffer sentences, and getting tough on drug dealers is only a small step to resolving the growing substance abuse in our country. I was disturbed recently when I was attending a number of junior high schools in the constituency of Kamloops. After the formal talks and presentations I arranged a lunch get-together with students who were interested in talking about issues. In every high school concerned students raised the matter of drug abuse in their schools. These were junior high schools, not senior high schools. Their views were that large percentages of the students were becoming regular drug users, and of course cigarette use was leading this initiative. As parliamentarians, all of us are concerned about this issue. Are we doing anything to come to grips with the fundamental causes of this growing use of drugs in our society? I think not. As a matter of fact, if I were going to be truthful with myself today I would say that we are taking a number of steps that will enhance drug abuse in the future, will make life more miserable for more Canadians, tougher for more Canadians, and will abandon more young people 15984 as a result of policies that are being considered or brought forward in these times. (1600) I appreciate the minister's intervention but perhaps in six months we will look at the record of Parliament and ask ourselves how much time we spent as elected representatives dealing with the fundamental causes of drug abuse in our country. That is the way we will measure whether we are taking this seriously. Mr. Paul Szabo (Mississauga South, Lib.): Mr. Speaker, the parliamentary secretary answered the first two items. I simply advise the member that under the three international conventions to which Canada is a party and to which Bill C-7 addresses the problem we have with, for instance, benzodiazepines, it is required that simple possession and use of marijuana remain a criminal offence. This is not an option for Canada in terms of opting out, as the member might suggest. We did not miss an opportunity. What we did was bring our legislation into line with the requirements of the international conventions to which Canada is a party. With regard to the attitude, I agree with the member. There is no question we have to look for every opportunity. Our national drug strategy spends 70 per cent of the moneys available to it on rehabilitation, treatment and prevention programs, most of which, as with regard to tobacco, directed at our young people, those most susceptible to these problems. I agree with the member that there should be a review. Our subcommittee of which I was the chair has recommended to the Standing Committee on Health and to the minister that a comprehensive review of Canada's drug policy and our overall drug strategy be conducted. Mr. Riis: Mr. Speaker, I appreciate the intervention by my hon. friend. I accept gratefully the comments he has made. A number of major initiatives have been taken as a result of our relatively comprehensive drug strategy. Let us also acknowledge that as a result of the transfer payment reductions now being imposed on the provinces, many of the programs they have in place will have to be curtailed or abandoned as a result. On one hand we might be expanding and on the other hand we are making it more difficult for provincial jurisdictions to continue their programs. I quote the Prime Minister when he was the justice minister in Pierre Trudeau's government in 1980, referring to marijuana decriminalization: ``It is our intention to bring about changes which will serve to lessen the severity of penalties for possession of this substance''. Granted my friend has said what is true, but in 1980. This legislation does not do that. It continues with the same penalties we have had in the past. Ms. Hedy Fry (Parliamentary Secretary to Minister of Health, Lib.): Mr. Speaker, I am distressed to hear the hon. member make the statements he did because I agree in every way with what he has said with regard to young people and the use of drugs. As a family physician, I can tell members that nothing has been of greater concern and has caused me more pain over my 25 years of practice. Voting against this bill would serve neither of the hon. member's objectives. It will really be throwing the baby out with the bath water. See this bill as a scaffold. See the recommendation the committee made to review this strategy as an open door to make very important changes that will be necessary. This is a springboard. It may not be all that he does, but voting against the bill will certainly throw away the opportunity. Mr. Riis: Mr. Speaker, I have been here for a few years and I have heard the same comments time and again that in dealing with major problems facing our country this is a tiny baby step in the right direction. This issue inflicts so much pain for so many people, for so many families, that not to do whatever possible to combat this is perhaps questionable in terms of our work here. I do not take these slight steps in the right direction with much enthusiasm but I accept that what she is saying is accurate. (1605 ) Mrs. Sue Barnes (London West, Lib.): Mr. Speaker, it gives me great pleasure to speak today on Bill C-7, the controlled drugs and substances act. Bill C-7 consolidates and supplements the Narcotics Control Act and parts III and IV of the Food and Drugs Act. It combines a regulatory scheme for drugs used in medicine with the criminal law regime for illicit substances. The bill is a reintroduction of Bill C-85, the Psychoactive Substance Control Act, introduced by the Conservative government in the previous Parliament. Bill C-85 died on the Order Paper in the last Parliament due to the election call. While it was reintroduced into this Parliament by the Minister of Health, aspects of it fall under the concerns of the Department of Justice and the Solicitor General of Canada. One main object of the bill as originally conceived was to bring our drug laws into conformity with provisions in certain international agreements we had signed. These agreements include the 15985 Single Convention on Narcotic Drugs, 1961, the Convention on Psychotropic Substances, 1971, and the relevant portions of the United Nations convention against illicit traffic in narcotic drugs and psychotropic substances, 1988. In keeping with the spirit of these instruments, Bill C-7 adopted an interdiction and criminalization approach to the production, traffic and the possession and use of illicit substances. The legislation was also supposed to cohere with Canada's drug strategy which had been unveiled in May 1987. The key object of the drug strategy is to reduce harm to individuals, families and communities caused by alcohol and other drugs. Canada's drug strategy was designed to place greater emphasis on reducing demand for illicit substances through prevention, education and drug treatment programs instead of relying solely on the interdiction efforts of police and penal institutions for the reduction of the supply of illicit drugs. In contrast to these methods, harm reduction seeks to reduce the harm caused by those who have a problem with substance abuse, including harm done to themselves, to their families and to other persons. It takes a public health approach to the problem of drug abuse rather than a moralistic, punitive one which views such abuse as criminal in and of itself. The bill passed second reading and was sent to a subcommittee of the Standing Committee of Health in April last year. As members will recall, the red book promised us that MPs would be given a greater role in drafting legislation through their work on House of Commons committees. The work done on Bill C-7 by the subcommittee chaired by the member for Mississauga South and the participation of other parliamentarians in making significant changes to the bill despite its having passed second reading is a perfect example of this commitment put into action. Officials from the departments of health and justice have explained that the bill was a consolidation of existing legislation and that the changes it contained were required to fulfil the international agreements we had signed. They emphasized that our international partners were exerting pressure on us to pass this legislation. As the subcommittee analyzed the bill more closely and listened to the arguments of witnesses a variety of issues began to emerge. Although there was not a single unanimous view, nonetheless members of each of the three parties expressed similar concerns about the substance of the bill, as did other parliamentarians including me. As many Liberals see it, Canada's approach to illegal drugs has required adjustment for some time. At different times the Liberal Party of Canada has in non-binding party resolutions advocated certain fundamental changes to our drug policies. To simply consolidate and thereby reaffirm existing approaches to drugs would be to miss an important opportunity to effect modern rational policies on drugs. What were the concerns some had with the original Bill C-7? Bill C-7 is a complex piece of legislation. In my view the following were among the most important concerns. First, the bill lacked provisions for rehabilitation and treatment options for sentencing as an alternative to incarceration or fines. Second, the bill categorized illicit substances according to outdated schedules. Third, the bill reaffirmed lengthy maximum prison terms and increased the fines for the simple possession of cannabis in contrast to current court practices and evolved societal attitudes. Fourth, Bill C-7 included a deeming provision for illicit substances which seemed to us to contradict the fundamental legal principle that conduct subject to criminal sanction should be specified clearly in acts. Let us deal with these concerns. First, the bill lacked provisions for rehabilitation and treatment options for sentencing as an alternative to incarceration and fines. Many members felt Bill C-7, drafted under the lead of the Department of Health, did not squarely address the public health dimensions of the illicit drug problem. Among experts in public health and addiction research, the consensus has emerged in recent years which emphasizes a strategy called harm reduction. It emphasizes the broader reduction of harms to society caused by illegal drug use, as well as by inappropriate institutional responses to drug problems. (1610) As the experts know, a harm reduction approach seeks to reduce the harm caused by those who have a problem with substance abuse, including harm done to themselves, to their families and to other persons. It evaluates strategies for dealing with illicit substances in part by situating them within the context of substance abuse generally, including that of alcohol and tobacco. A less ideological perspective on the problem begins with honest epidemiological comparisons to strategies for dealing with such legal and potentially very dangerous substances. Harm reduction initiatives include needle exchange programs, methadone treatment, counselling and rehabilitation efforts. Education efforts which stress the health risks associated with legal and illegal drug use are also important in the prevention of drug dependencies or addictions. I contrast this approach with what I would call prohibitionism. One treats the consumption of drugs as a moral evil where criminal sanction is seen as the only appropriate response. Rather than recognizing the users of illicit substances as endangering their health and taking appropriate steps to help them, the prohibitionist perspective would treat them solely as criminals who require the 15986 threat of criminal penalties and a criminal record to deter them from such behaviour. Were this an effective approach, the United States with its heavy emphasis on interdiction and punishment would be nearly drug free by now. As we know, the number of prisoners in jail for drug offences in that country continues to grow with little sign of any stemming of the insidious drug trade or the use of illegal drugs. Despite being part of Canada's drug strategy which emphasizes harm reduction as its primary goal, Bill C-7 in its original form did not mention or encourage judges to consider rehabilitation or treatment as alternatives to fines or incarceration for those convicted of possession of illicit substances. This was a concern now remedied. Criminal sanctions should not be our only tool for dealing with illicit drugs or for changing the habits of persons who are addicted or at risk of drug addiction. Prohibitionism toward drug users on its own arguably inflicts greater harms on individuals and families than the harms it purports to prevent. We should also bear in mind the far greater number of deaths and amounts of disease associated each year with the use of such legal drugs as tobacco and alcohol. In my opinion the sums and energies we expend in fighting the use of illicit drugs should be allocated with due regard for their overall impact on population health. Wisely and responsibly, the government has amended Bill C-7 to include a clause that addresses rehabilitation. Clause 11(1) declares: ``The fundamental purpose of any sentence for an offence arising under part I is to contribute to respect for law and the maintenance of a just, peaceful and safe society, while encouraging rehabilitation and treatment in appropriate circumstances of offenders and acknowledging the harm done to victims and to the community''. The second concern I raised was that the bill categorized illicit substances according to outdated schedules. No one would dispute our drug policy must be reflective of current scientific knowledge. The parliamentary committee repeatedly stressed the schedules proposed in Bill C-7 are outdated. This was put forward by witnesses. While they are housed in the 1971 UN convention, their arrangement derives from public policies of the 1920s when policy makers knew relatively little science about the nature, the effects and the potential for societal harm posed by these drugs. The most serious example of the lack of pharmacology reflected in the schedules was the placement of cannabis in the schedule I of the UN convention. Schedule I is supposed to be reserved for the most socially harmful drugs such as morphine, heroin and opium. Heavy regular use of cannabis can certainly sap motivation and affect short term memory. Many will contend that while it may be carcinogenic, the risks of the light use of cannabis do not appear to be significantly worse than those associated with moderate use of legal substances like alcohol. While we have heard calls from some for decriminalization, in my opinion dependency on marijuana should be strongly discouraged. Nonetheless, the drug schedules used in Canada should reflect the best scientific knowledge we possess. We should not be obligated to accept outdated schedules. In response to the concerns raised, the bill has been amended to incorporate an additional schedule, I(i), which deals exclusively with cannabis and its derivatives. Read together with the new penalty provisions which I shall discuss next, this amendment takes cannabis out of the company of far more deleterious drugs like heroin and cocaine while keeping it within the realm of the Criminal Code. In a minute I will also discuss the international schedules and our response to that issue. (1615) The third concern with the original Bill C-7 was it reaffirmed maximum prison terms and increased the fines for the simple possession of cannabis, in contrast to current court practices and involved societal attitudes. Should pot smokers have the threat of a lengthy jail term hanging over their heads? Is this the best way to discourage use? Does it make Canada safer? Does it make it healthier? As originally drafted, Bill C-7 retained a maximum penalty of seven years for simple possession of cannabis. It doubled the fine for a first offence and more than doubled it for a second offence. These maximum penalties contrasted with what is generally now meted out by Canadian courts for a first time offence, which is usually a small fine and sometimes an absolute discharge. It is estimated that we charge over 40,000 people a year with simple possession of cannabis, a costly burden on the court and the police systems. This represents approximately 3 per cent of the estimated over one million regular cannabis users in Canada. Further, while 3 per cent of those charged will face incarceration, over half a million Canadians have criminal records because of cannabis convictions. These people can apply for pardons in due course, since the convictions that they have can be a serious hindrance for employability and for travel. Penalties tend to vary with different police officers, the judges, the regions of the country and the socioeconomic status of the accused. Would that it were not so, but it is true. In many communities across Canada, the courts, the legal profession, the police on the beat and the average person do not appear to view cannabis possession as meriting the severe penalties set out for it in existing law. Reaffirming these penalties would effectively express our legislator's faith in the existing penalty structure. What signals should such reaffirmations send to our courts? When law lags behind court practices and societal attitudes 15987 and such laws come up for review, the laws must be adjusted, not reaffirmed. Penalties for offences under the act should be proportionate to the social and personal harm they entail. In keeping with this principle, the bill has been amended to incorporate a new schedule which establishes threshold amounts of cannabis for the offence of simple possession. Persons charged with possession of lesser amounts will be subject only to summary conviction proceedings, with a correspondingly lower range of penalties. This is still a criminal conviction and I stress this. However, in those cases involving the lesser amounts with simple possession charges, there will not be fingerprinting, there will not be photography or entering into a CPIC system for tracing purposes. By reducing penalties and recommending treatment and rehabilitation alternatives in Bill C-7, we send a clear signal to the courts encouraging them to pursue the available harm reduction avenues. The fourth concern I originally mentioned, that the bill as originally drafted included a deeming provision for illicit substances which appears to contradict the fundamental legal principle that conduct subject to criminal sanction should be specified clearly in acts. The deeming provision in Bill C-7 allowed new, previously unscheduled substances to be deemed by regulators to belong to a particular schedule and the attached penalty provisions to come into force at that point. The bill would have extended a definition of controlled substances and their analogues beyond drugs cited in the schedules, to such drugs as were deemed by regulators to have an effect substantially similar to, or greater than, schedule substances. Using this provision, the government would thus have been able to adopt regulations to control, govern and limit the use of as yet undesignated substances. This would be a significant departure from current provisions of the Narcotic Control Act and the Food and Drugs Act, the offences and associated punishments set out in these acts would apply only to such drugs as are specifically cited in the attached schedules. The purpose of this provision would be to allow regulators to respond quickly to the introduction of new so-called look alike drugs on our streets. While this purpose is laudable, it has yet to be shown that this problem of undesignated drugs is out of control and in guarding against it, we must be careful not to trample on other fundamental legal principles. Citizens must know what the law is beforehand, so that they can govern their behaviour accordingly. If something is illegal, then there must be a law saying so unambiguously. To declare x a crime after the fact is unacceptable. Further, many consumers and vendors of natural health remedies expressed concern that this provision could allow regulators to declare these products included in restricted or banned schedules. This provision, in fact, only dealt with parts III and IV of the Food and Drugs Act and herbs have historically been covered by parts I and II. Accordingly, this provision has been deleted now as the amended act Bill C-7 by the government. (1620 ) I have dwelt at some length on the substantial improvements that members were able to bring to this bill after second reading. Most of my remarks have concerned the demand side of the drug equation. There is also the supply side to consider. Bill C-7 introduces three important measures to combat drug trafficking. First, it includes a provision whereby judges are required to take aggravating factors into account when sentencing. Written reasons will now be required of a judge who fails to impose a prison term in the presence of any one of a list of aggravating factors. The court will be required to regard as aggravating factors: first, use of a weapon or use of threat of violence; second, trafficking on school grounds or to a minor or in or near public places frequented by minors; third, any previous convictions of a drug offence and fourth, using the services of a minor in the perpetration of a designated substance offence. It is anticipated and hoped these provisions will deter drug dealers from using weapons, threatening violence, selling to young people or recruiting their services. Second, schedule V in Bill C-7 introduces the notion of precursor substances, adding them to the list of controlled substances. This innovation keeps us in line with our international obligations under the single convention on narcotic drugs, 1961 and the 1988 Vienna convention. Precursors do not by themselves produce any psychotropics or psychoactive effect but can be converted or used to produce designer drugs, look alike drugs or scheduled substances. Regulations enacted to control the import and export of precursors would attempt thereby to thwart the production of psychoactive substances in Canada and elsewhere. Canada has become a conduit for these and we owe it to our international partners to put a stop to this. Finally, Bill C-7 allows police to use reverse sting measures, that is selling quantities of drugs to dealers for the sake of making arrests. Under the regulations of the Narcotic Control Act police officers have been permitted to possess drugs as part of their undercover work but without legislative authority to sell. Quite reasonably they wish to have clarified that they are so permitted by including a clause exempting them from the criminal provisions of the new act. That has been done. Legislation is an evolutionary process as it should be. I believe that Bill C-7, as amended, has come a long way. The subcommittee has also recommended that a comprehensive drug policy review be undertaken by a parliamentary committee. Further, there has also been a recommendation that a task force of experts be established to examine and redefine the criteria for the the scheduling of drugs. Thus Canada could be a leading force in the modernization of international drug scheduling. 15988 Although I admit to not being an expert in these matters, I do know that it is the time to look forward to a drug policy appropriate to the 21st century, one that incorporates criminal law, enforcement, public health and modern societal attitudes. I publicly commend our ministers, the subcommittee members and our colleagues in the House of all parties in the development of the bill as deliberated today and I will support it. Mr. Reg Alcock (Winnipeg South, Lib.): Mr. Speaker, in listening to the remarks of the member for London West we see the excellence that is brought to the work of this Chamber. I want to speak very briefly on the process rather than the substance of this bill. For me the bill personifies and represents everything that is good about what we said we would do when we came to this House. The very low number it has, Bill C-7, should indicate to members that a considerable amount of time has elapsed between the time this bill was introduced and today. The reason for that is quite simple. We said when we campaigned in the election in 1993 that we would introduce processes that allowed backbench members to get involved in a hands on way with the drafting of important legislation, which is exactly what happened with this bill. The members for Vancouver East, Beaches-Woodbine, Oakville-Milton, Fredericton-York-Sunbury, London West, Etobicoke-Lakeshore, Saint-Denis, Lachine-Lac Saint-Louis and many others spent hundreds of hours arguing through the articles of this bill. They were concerned. This bill is a holdover from the previous government. As many members have said, when they first heard the testimony they thought something was wrong, that the bill did not meet the test that we campaigned on. Members of this House worked exceptionally hard with the full support of three ministers, the Minister of Justice, the Solicitor General of Canada and the Minister of Health. They struggled to improve the bill and have it reflect the principles and the values which our party brings to this House. In so doing, we received tremendous support from staff in the various ministries. I want to single out an individual, Mr. Paul Genest, from our research bureau who put in all of those hours with each of these members as they thought through, argued through and worried about the details. It is not easy being a backbencher and approaching legislation in the face of a cadre of experts, lobbyists and in this case people from other countries who come in and say that the legislation must be written in a particular way to meet their particular needs. It took a long time. It took much thought. It took very hard work. I believe we have produced legislation that will, as the member for London West has suggested, put Canada in the forefront of leading the war on drugs from a perspective of harm reduction and not simply following the U.S. model that was established earlier in the eighties under Ronald Reagan. This whole process has been an exercise in excellence and one in which our caucus should be very proud. I want to thank those members on the staff and in this caucus who worked so hard to do what we said we would do when we came here and that is allow every member of this House a hand in drafting important legislation. [Translation] The Deputy Speaker: Is the House ready for the question? Some hon. members: Question. The Deputy Speaker: Is it the pleasure of the House to adopt the motion? Some hon. members: Agreed. Some hon. members: No. The Deputy Speaker: All those in favour will please say yea. Some hon. members: Yea. The Deputy Speaker: All those opposed will please say nay. Some hon. members: Nay. The Deputy Speaker: In my opinion the yeas have it. Some hon. members: On division. (Motion agreed to, read the third time and passed.) [English] Mr. Don Boudria (Glengarry-Prescott-Russell, Lib.): Mr. Speaker, I move: That the House do now adjourn. The Deputy Speaker: The House has heard the terms of the motion. Is it the pleasure of the House to adopt the motion? Some hon. members: Agreed. Some hon. members: On division. (Motion agreed to.) The Deputy Speaker: Under our standing orders, the House stands adjourned until tomorrow at 10 a.m. (The House adjourned at 4.28 p.m.) To return to CFDP home page: http://fox.nstn.ca/~eoscapel/cfdp/cfdp.html